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ABSTRACT 
The envelopment and egress of the Herpes Simplex Virus is an important event in the life 
cycle of the virus. The important membrane proteins required for the envelopment and 
egress of the virus are glycoproteins gM, gK, gE and non-glycosylated membrane 
proteins UL20p and UL11. Among them one of the most critical protein is the UL20 
protein which has four transmembrane domains with amino and carboxyl termini are 
predicted to lie within the cytoplasmic side of cellular membranes. Studies done in our 
laboratory have shown that deletion of UL20 or other lethal mutations have an adverse 
effect on envelopment and results in accumulation of unenveloped capsids in the 
cytoplasm of infected cells. The carboxyl termini of UL20 protein was shown to be 
extremely important for viral egress. Mutant viruses were made with mutations in the 
carboxyl termini of UL20p especially targeting phenylalanine residues as they are known 
to be an important target for protein-protein interactions through stacking of the aromatic 
structure. The two membrane proximal phenylalanines were very critical for efficient 
replication as well as envelopment whereas, the middle phenylalanine at the carboxyl 
terminus may have a negative effect with regard to the virus since the mutation helped 
the virus to replicate, envelop and egress better.  
Another glycoprotein shown to be playing a role in viral entry to susceptible cells or 
neurons is Glycoprotein K (gK) especially the amino terminus of the protein. If the virus 
has entered the cell but failed to enter nucleus and start protein synthesis, it is very 
difficult to assess the entry of virus. In this scenario, the virus may be either stuck at the 
cell membrane or the transport to the nucleus is adversely affected. In order to 
demonstrate the entry of virus at a very early time point is quite challenging, but through 
vii 
 
Proximity Ligation assay (PLA) we have showed the importance of gK, the defect or less 
efficiency of gK mutant virus in entry to epithelial cultured cells as well as in neurons at 
a very early time point post infection.  
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CHAPTER I 
INTRODUCTION 
Statement of Problem and Hypothesis 
The most common manifestation of HSV-1 infection is primary herpetic 
gingivostomatitis (PHGS) characterized by transient painful vesicles in and around mouth 
which often affects the quality of life rather than a serious infection. Ocular herpes viral 
infection is considered as the leading cause of infectious blindness in developed 
countries. The herpes virus is capable of establishing latency in the trigeminal ganglia. So 
once infection occurs, then they are incurable and persist throughout the lifetime of the 
host. Apart from recurrence that occur spontaneously, there are a many extrinsic and 
intrinsic factors that can cause viral reactivation like stress, exposure to sunlight, 
menstrual cycle, immunosupression, treatment with corticosteroids, and trauma. The 
double-stranded viral DNA genome is enclosed within an icosahedral nucleocapsids, 
surrounded by proteinaceous tegument layer and lipid envelop embedded with 
glycoproteins. 
Envelop proteins play an important role in the life-cycle events of HSV-1 like 
envelopment/egress and entry. It is believed that the virus acquire a primary envelope 
when mature capsid bud from nucleus to perinuclear space. De-envelopment results from 
the fusion between outer nuclear membrane and viral envelopes and the capsids released 
to the cytoplasm of infected cells undergo secondary envelopment in cytoplasmic 
vesicles derived from trans-golgi network (TGN) or endosomes and final egress happen 
to extracellular space [1]. Till date nobody has proved the exact mechanism and viral 
proteins involved in envelopment and egress. 
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Studies conducted in our laboratory have shown that UL20 protein serves crucial roles in 
cytoplasmic virion envelopment in comparison to other viral glycoprotein [2]. Deletion of 
just either 6 (UL20∆216t) or 11 amino acids (UL20∆211t) allowed efficient UL20p 
intracellular transport and cell surface expression, but failed to complement for infectious 
virus production affecting the envelopment and egress. Phenylalanine residues are 
aromatic and hydrophobic amino acids that have been shown to play an important role in 
respiratory syncytial virus assembly [3]. We hypothezis that phenylalanine at the 
carboxyl terminus of UL20p are important for virion envelopment and egress. 
Another important Glycoprotein in the virion envelop is gK which plays multiple roles in 
viral entry, virion fusion, egress and envelopment [2, 4-6]. It has been shown that gK is 
important for viral corneal spread and neuroinvasiveness [7] as well as for both 
retrograde and anterograde spread along axons of neurons [8]. Deletion of amino 
terminus of gK (gK31-68) slowed the entry of virus into epithelial cells [6]. PLA has 
been a novel technique to explore protein interactions using DNA along with processes 
like ligation, cleavage, and polymerization [9]. We also hypothesize that through PLA 
experiments showing association between inner tegument protein UL37 and motor 
protein dynein can be utilized to show the delay in the entry of gK amino terminus 
mutant to epithelial and neuronal cells. 
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Statement of Research Objectives 
The main aims of this research was to investigate the importance of carboxyl terminal of 
UL20p in HSV-1 with regard to virion envelopment and egress with special emphasis on 
aromatic amino acid phenylalanine and also to investigate the role of gK with regard to 
entry in both epithelial and neuronal cell culture. 
The research objectives were: 
I. To investigate the role of carboxyl terminus amino acids of UL20p especially 
phenylalanine residues in virion replication and spread: 
1. To generate and validate a set of mutant viruses having deletion of 
phenylalanine residues at the carboxyl terminus or replacement of them 
with alanine residues in HSV-1 (F) VC-1 genome cloned on bacterial 
artificial chromosome (BAC) using two-step red double recombination 
method. 
2. To characterize the phenotypes of mutant viruses using plaque 
morphology, fusogenic capacity using luciferase assay, expression 
profiling using immunoprecipitation/western blotting and virus replication 
curves. 
II. To investigate the role of phenylalanine residues at the carboxyl terminus of 
UL20p of HSV-1 with regard to viral envelopment and egress: 
1. To analyze the ability of mutants to envelop and egress using q-PCR, and 
to study the transport of UL20p to TGN, an important step during 
envelopment, using confocal microscopy through colocalization. 
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2. To compare the interaction of UL20p with an important tegument 
proteinUL37 during envelopment of mutant viruses with wild-type virus 
using proximity ligation assay (PLA). 
3. To investigate the ultra structural phenotype of viruses with phenylalanine 
mutations on carboxyl-terminus of UL20p exhibiting defects in virion 
egress and spread.  
III. To investigate the role of amino terminus HSV-1 gK with regard to entry in 
both epithelial and neuronal cell culture. 
1. To standardize and utilize the PLA technique in studying the entry of 
HSV-1 virus to cells. 
2. To compare the defects of gk mutant viruses for entry in both epithelial 
cells and neuronal cells by acquiring signals of PLA in confocal 
microscope. 
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CHAPTER II 
REVIEW OF LITERATURE 
History of Herpesviruses 
The occurrence of human herpes simplex virus infections was documented in the ancient 
Greek times. The Greek scholar Hippocrates described the lesions using the word 
“herpes” which means to creep or crawl along the skin [10]. The link between cutaneous 
lesions caused by HSV and the related fever was pointed out by Herodotus and 
recurrence of the lesion at same anatomic site was recognized by Galen [11]. In 1736 
John Astruc, a physician for King Louis XIV of France published De Morbis Veneris 
after he found a connection between HSV and the genital organs after studying the 
disease in French prostitutes [12]. Later in the early 19th century Thomas Bateman 
described herpes as “a restricted group of localized vesicles with a short, self-limiting 
course” (Bateman, 1814). In 1873, Vidal demonstrated that the disease was infectious 
and can cause reinfection in a new anatomical site by re-inoculating the herpetic lesion 
materials.  
During early 20th century, Cushing from his observations came up with the concept of 
latency by suggesting that posterior root ganglia were responsible for the occurrence of 
herpes [13]. Gruter is credited for using an animal model for showing the infectious 
nature of virus by studying the spread of HSV among rabbits and he is acknowledged for 
the isolation of the virus [14].  As a therapeutic measure herpetic vesicular fluid was 
inoculated into forearm skin in both animals well as in humans [15]16].  
Later new technologies like tissue culture accelerated the isolation and identification of 
other viruses in the herpes family. In 1950’s, Vericella Zoster Virus (VZV), causative 
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agent of chicken pox, and cytomegalovirus (CMV) [17], immune system associated 
herpes viruses like human herpesvirus 4 (HHV-4; Epstein-Barr virus) [18] and human 
herpesviruses 6A, 6B, and 7 [19, 20] were isolated as a result of cultivation of 
lymphoblastoid tumor cells, B cells and T cells respectively.   Newly, human herpesvirus 
8 was isolated through Representational Differential Analysis (RDA) [21]  
Taxonomy of Herpesviruses 
Herpesviruses are complex viruses due to their large genomic size and a complicated 
lifecycle. The human Herpesviridae family consists of eight members: HSV-1 and 2 as 
well as varicella-zoster virus (VZV) under subfamily Alphaherpesviruses, human 
cytomegalovirus (HCMV) and roseoloviruses (HHV-6 and -7) under Betaherpesviruses 
and Epstein-Barr virus (EBV), Kaposi-sarcoma herpesvirus (KSHV) under 
Gammaherpesviruses. Table 1.1 summarizes all the nine known human herpesviruses 
along with commonly studied herpesviruses [22, 23]. 
Alphaherpesvirinae subfamily was classified on factors like diverse host range, short 
reproductive cycle, fast spread in tissue culture, efficient lysis of susceptible cells and 
establishment of latency mainly in sensory ganglia. Genera’s included under the 
subfamily include Simplexvirus, Varicellovirus, Marek’s disease-like virus, and 
Infectious laryngotracheitis-like virus [23]. 
Betaherpesvirinae subfamily was classified on factors like small host range, long 
reproductive cycle, and slow progression of infection on tissue culture. Infected cells are 
characterized by enlargement called cytomegaly, and viruses are capable of going latent 
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Table 1.1: Members of the family Herpesviridae 
 
Subfamily 
 
Designation 
 
Vernacular Name 
Alphaherpesvirinae Human herpesvirus 1 (HHV-1)  
Human herpesvirus 2 (HHV-2)  
Human herpesvirus 3 (HHV-3) 
 
Gallid herpesvirus 1 (GaHV-1) 
Gallid herpesvirus 2 (GaHV-2) 
Suid herpesvirus 1 (SuHV-1)  
Felid herpesvirus 1 (FeHV-1)  
 
Ictalurid herpesvirus 1 (IcHV-1) 
Bovine herpesvirus 1 (BoHV-1) 
Equid herpesvirus 1 (EHV-1) 
Herpes simplex virus type 1 (HSV-1) 
Herpes simplex virus type 2 (HSV-2) 
Varicella-zoster virus (VZV), shingles, 
chicken pox. 
Infectious laryngotracheitis virus 
Marek’s disease virus 
Pseudorabies virus, Aujesky’sdisease virus 
Feline herpesvirus 1, Feline rhinotracheitis 
virus 
Channel catfish herpesvirus 
Infectious bovine rhinotracheitis virus 
Equine HV-1, Equine abortion virus 
Betaherpesvirinae Human herpesvirus 5 (HHV-5)  
Human herpesvirus 6A (HHV-6A) 
Human herpesvirus 6B (HHV-6B)  
Human herpesvirus 7 (HHV-7) 
Cytomegalovirus (CMV) 
 
Roselovirus 
Gammaherpesvirinae Human herpesvirus 4 (HHV-4)  
Human herpesvirus 8 (HHV-8) 
 
Canid herpesvirus 1 (CaHV-1) 
Ovine herpesvirus 2 
Epstein-Barr virus (EBV) 
Kaposi's sarcoma-associated herpesvirus 
(KSHV) 
Canine herpesvirus 
Sheep-associated malignant catarrhal fever 
 
in secretory glands, kidneys and other tissues. Genera’s included in the subfamily are 
Cytomegalovirus, Muromegalovirus, and Roseolovirus [23]. 
Gammaherpesvirinae subfamily was classified on factors like limited host range and 
ability to replicate in lymphoblastoid cells. Latency has been frequently shown in 
lymphoid tissues and viruses are specifically for B cells or T cells. The genera’s included 
are Lymphocryptovirus (EBV), and Rhadinovirus [23].  
Structure of Virus 
HSV-1 genome consists of double-stranded DNA enclosed within an icosahedral 
nucleocapsid, which is surrounded by a lipid envelop embedded with glycoproteins. 
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Between nucleocapsids and envelope lies a proteinaceous layer called tegument (Fig 1.1). 
The nucleocapsid houses DNA, in a densely coiled liquid crystalline arrangement [24] 
and it is one of the similarities HSV-1 shares with bacteriophages [25]. There are three 
types of capsids isolated from the viral infection, A, B, C capsids. They are icosahedral in 
shape and were made of 162 capsomers, but the difference was in their core content. 
Only capsid C contains viral DNA and are able to mature to infectious virus [26, 27]. An 
additional structure found in the C capsids or the capsids in the complete virion is the C 
capsid specific component (CCSC) and is absent in the A or B capsids of virus.[28]. 
Works done both in vivo and in vitro has shed light on the pathway for HSV-1 capsid 
assembly [26, 29, 30]. Capsid shell is made of proteins UL19, UL35, UL18, UL38 and the 
scaffolding protein UL26.5 which is lost during maturation of procapsid to mature capsid. 
Portal system is a ring shaped structure made of which viral DNA enters and exit from 
the capsid [31, 32]. The viral envelop is made up of 11 glycoproteins and the tegument is 
made of 20 virally encoded proteins. 
Mostly viruses are observed as round shape although they could be in different shapes. 
The lipid bilayer is around ∼5 nm thick and the diameter ranged between 170 to 200 nm. 
The diameter taking into account membrane proteins decorating the envelope averages 
∼225 nm. Nucleocapsid occupied an eccentric position inside the envelope and linkers or 
∼4 nm connected tegument cap with the envelope. There number of protein spikes on the 
envelope varies from 600 to 750. The spikes are 10 to 25 nm long, ∼4 nm wide and 
ended in a globular structure ∼6 nm across. There are variation in the angles of 
protrusion and straightness of spikes [25] 
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two inverted pentanucleotide repeats, boxes I and II of the HSV-1 origin of replication, 
OriS. UL9 protein also possesses DNA-dependent ATPase and 3′-5′ helicase activities 
[35] The six important proteins for replication are: a single-strand DNA-binding protein 
(known as ICP8 or UL29), a two-subunit DNA polymerase (catalytic subunit Pol and 
processivity subunit UL42), and a three-subunit helicase/primase complex (H/P:UL5, 
UL8, and UL52)[36]. H/P complex is recruited once ICP8 and UL9 have unwounded the 
DNA at the site of replication. Subsequently polymerase complex is recruited for DNA 
synthesis leading to the formation of tandem head to tail concatemeric DNA which 
accumulate in the nuclei which are later cleaved at regular intervals to monomeric units 
and finally encapsidation to generate progeny virus. There is a higher rate for 
recombination among herpes viruses [37]. 
Clinical Manifestation 
HSV-1 is more important causative agent than HSV-2 in causing ocular disease, 
characterized by conjunctivitis, iridocyclitis, acute retinal necrosis and keratitis. HSV-2 is 
the main culprit behind various genital infections and is a sexually transmitted disease 
[38, 39].We could notice an endemic pattern of distribution for herpes virus infection in 
the natural human host of the virus throughout the world irrespective of level of 
civilization that is from highly developed urban population to native tribal population 
[40]. Predilection sites for latency occurs in trigeminal ganglia for HSV-1 and sacral 
ganglia for HSV-2 as they cause infections in the face and genital areas respectively.  
Recurrent infection of herpes virus is not considered as reinfection by virus, but it is due 
to viral reactivation from latency [41]. Apart from recurrence that occur spontaneously, 
there are  many extrinsic and intrinsic factors that can cause viral reactivation like stress, 
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exposure to sunlight, menstrual cycle, immunosuppression, treatment with 
corticosteroids, tissue damage and trauma [42]. Viral reactivation not always leads to 
clinical manifestation of disease, but can cause asymptomatic shedding of virus known as 
recurrence [39, 43] and viral reactivation with clinical signs of disease are known as 
recrudescence. Transmission of HSV-1 occurs mainly through oral secretions and lesions 
are mainly associated with eyes, face, pharynx, and central nervous system infections. 
The ability of virus to remain viable on fomites and skin helps in horizontal transmission 
through social contacts like kissing and shaking hands [44, 45]. There are two kinds of 
initial herpes virus infections; a) True primary infection and b) nonprimary infection. 
True primary infection occurs when a HSV-1 seronegative individual gets infected with 
the virus and the infection usually more severe and having a prolonged duration of viral 
shedding [38, 46, 47]. Nonprimary infection occurs when a new strain of HSV-1 infects 
an already infected person with another strain of HSV-1 [38, 48]. Primary infection is 
characterized by elevated levels of IgM, while in the case of nonprimary infection there is 
an elevated level of IgG. The most common manifestation of HSV-1 infection is primary 
herpetic gingivostomatitis (PHGS) characterized by transient vesicles in and around 
mouth [49]. Spread of virus to new hosts or different regions of the body is facilitated by 
rupture of the vesicles. The most common form of recurrent herpes infection is Herpes 
simplex labialis characterized by the presence of painful vesicles on the outer vermilion 
border and adjacent cutaneous region [50] which heal in a span of 2 weeks, but 
dissemination of virus continues for 3 to 5 days after healing [51].  
Herpes infection is considered as the leading cause of infectious blindness in the 
developed countries [52]. Ocular manifestation can be the result of primary infections or 
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recurrent infections. HSV epithelial keratitis initiates as a superficial punctate lesion, 
developing to a stellate erosion and ultimately leading to dendritic ulcer [53, 54]. 
Although immune system is capable of clearing the infection, virus can travel retrograde 
axonal transport through sensory neurons before establishing latency in the trigeminal 
ganglia. So once infection occurs, then they are incurable and persist in latent infection 
throughout the lifetime of the host. Primary evidence for the transport of virus to central 
nervous system came to notice  as the virus causes herpes encephalitis [55]. Areas of 
brain damaged by the virus are the anterior perforated substance, amygdala, insula, 
hippocampus, mammillary bodies and cingulate gyrus [56-58]. There are two schools of 
thoughts regarding entry of the virus to brain. A) Entry may be through trigeminal nerve 
and reach meninges covering the temporal lobe [59], from there infecting limbic system 
structures. B) Entry to brain through the olfactory system [60]. HSV-1 and -2 and VZV 
can cause facial, genital ulcers and in rare cases encephalitis.  CMV infection is of 
concern in immunocompromised people and HHV-6 as well as HHV-7 cause exanthum 
subitum or roseola infantum in infants. Whereas, EBV causes infectious mononucleosis 
and can exist in latency in individual’s B cells and KSHV causes Kaposi's sarcoma. 
HSV-1 and HSV-2 share similarities in their genomic sequence, but since their envelope 
proteins differ they are considered antigenically distinct [38, 44]. 
Epidemiology 
Studies have shown that seroprevalence of HSV-1 is greater than 50%, 75% and 90%  in 
the general adult populations of the countries the United States, Germany, and Tanzania 
respectively [61, 62]. Thus most of the people are infected with HSV-1 and carry a latent  
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infection in them. In the United States, around 500,000 people have ocular HSV and the 
country has to spend 17.7 million US$ annually for the treatment of the disease [63, 64]. 
Additionally, incidence of HSV-1 infection is greatly influenced by race as well as socio-
economic condition. By the age of 5 years, 35% of black kids are seropositive  for HSV-1 
antibodies in comparison to 18% of white kids [65]. Whereas, 33% of kids in lower 
socioeconomic background are seropositive for the infection by the age of 5 years and 
percentages reach up to 70 -80 % by late puberty [65, 66]. In contrast, only 20% of kids 
in higher socioeconomic background are seropositive for HSV-1 by age 5 and 40% to 
60% by late adolescence [42, 65]. 
The world wide prevalence of HSV-1 comes to be around 90%, whereas prevalence in 
United State of America is 65% [67] and in northern Europe 52-67% [68].  The generally 
accepted facts are 1) Latency is due to failure to start the expression of  immediate early 
genes (IE); 2)  Latent DNA is maintained in a non-linear configuration as a circular 
episome; 3)  The latency-associated transcripts (LATs) are the only viral gene products 
produced in latently infected cells; 4) Finally reactivation causes activation of virus gene 
expression and entry into lytic phase [69].  
The molecular basis of Herpes Simplex Virus latency 
All herpesviruses have the unique characteristic ability to establish life-long latency in 
the infected host. The latency can be periodically interrupted leading to reactivation and 
dissemination of infection to newer host upon instances like immunosuppression. This is 
a highly efficient survival system they have evolved to maintain as well as to perpetuate 
infection. After primary replication in the oral mucosa, HSV-1 virus enters the sensory 
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neuronal termini innervating the site of infection and is carried in a retrograde direction to 
establish latency in the trigeminal ganglia.   
 An important event for lytic cascade is the association of VP16 viral protein with 
two cellular factors, Octamer binding protein-1 (Oct-1) and host cell factor (HCF) and 
binding to TAATGARAT region in the promoter sequence for the five IE genes ICP4, 
ICP0, ICP22, ICP27, and ICP47 [70]. The basic requisite for latency is failure of IE gene 
activation. This could be due to inadequate quantity of VP16 reaching the neuronal 
nucleus after the virus traverses long distance through the axon [71]. HSV latency 
associated promoter has been associated with acetylated histone H3, whereas decreased 
association have been seen for IE as well as early gene promoters through chromatin 
immunoprecipitation studies [72, 73]. Only expressed viral gene product during latency 
are LATs, which are polyadenylated non-coding RNA. They are transcribed from repeat 
regions flanking the unique long regions of herpes viral genome[74]. The size of primary 
transcript is 8.3kb and which then subsequently spliced to 2.0 kb intron and finally into 
1.5 kb intron [75]. Studies have shown that the of 3′ end of the first exon and 5′ end of the 
stable 2.0 kb LAT intron protects the cells from going into apoptosis [76].  
Herpes virus encoded miRNAs play important roles in latent/lytic cycle control, evasion 
of immune system, and cellular survivability [77]. HSV-1 encodes 16 siRNAs and of 
which six miRNAs (miR-H2, H3, H4, H5, H7 and H8) are encoded within the 8.3 kb 
primary LAT [78]. Co-transfection studies have shown that miR-H2 and miR-H6 
decreased the amount of proteins ICP0 and ICP4, showing the part played by miRNA in 
suppressing the lytic phase and supporting the latent state of infection. The virus has 
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shown to encode several proteins gD and gJ, as well as protein kinase Us3, ICP27 and 
ICP10 to prevent apoptosis of cells [33, 79-81]. 
 As mentioned before, the key factor for a cell to enter lytic cycle is counting on 
the transactivating function of the viral protein VP16 and formation of a complex with 
HCF-1 and Oct-1 [70]. There has been a school of thought that in case of neurons VP16 
may be inefficiently transported through the axons leading to an insufficient 
accumulation in the neuronal cell body [71]. The unique cytoplasmic localization of 
HCF-1 [82]  and down regulation of Oct-1 [83] in neuronal cells were roadblocks in the 
formation of VP16-induced complex leading to suboptimal activation of IE promoters 
and subsequent latency stage. However, till now no study is able to find the reason 
behind why the virus cannot go latent in vitro.  Most of the latency studies have been 
done in mice, but reactivation does not cause reinfection at the site of infection like in 
humans. Most common stimuli used for in vivo reactivation are the use of adrenergic 
agents like epinephrine. 
Immune Response against HSV-1 
Viral replication in the peripheral epithelial cells activates the innate immune response 
through type 1 interferons (IFNs) released by macrophages and the interferons help to 
protect neighboring susceptible cells from infection. Neutrophils invading the site of 
infection cause apoptosis of infected cells and also phagocytes them. Macrophages in the 
primary site of infection and in the trigeminal ganglia play a vital role in controlling viral 
replication [84, 85]. Table1.2 has summarized the HSV-1 pathogen recognition receptors 
(PRRs) and the corresponding pathogen associated molecular patters (PAMPs). 
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Dendritic cells (DCs) take up the viral proteins and process them to present to 
lymphocytes to activate adaptive immune system [86]. Activated T lymphocytes, T-
helper (CD4+) and cytotoxic T cells (CD8+) take part in clearing infection. Whereas, B-
cells play the role of presenting antigens and secreting cytokines rather than producing 
neutralizing antibodies [87]. The unmethylated CpG motifs on HSV-1 genome is detected 
by Toll-like receptor 9 (TLR-9) in the membrane of endosomal compartments. Whereas, 
PRR TLR-9 on plasmacytoid DCs and B cells can detect endocytosed DNA of HSV-1 
[88, 89]. Recognizing herpes virus by TLR2 causes an influx of inflammatory cytokines 
in the brain leading to encephalitis [90]. Pathogen recognition receptor (PRR) TLR-3 can 
recognize dsRNA in the endosomes which are intermediate in herpes viral replication 
[91]. Studies have shown that susceptibility for herpes encephalitis is more in children 
who are genetically deficient in TLR-3 receptor [92-94]. Most of the TLRs signal through 
adaptor myeloid differentiation primary response gene 88 (MyD88) for producing 
downstream type I IFNs [95, 96]. Innate immune response is critical for controlling viral 
replication at the site of infection. Studies have shown that in IFN A1 receptor knockout 
mice where type I IFN signaling is absent results in higher host morbidity and mortality 
[97, 98]. Cytosolic short dsRNA and longer dsRNA of herpes virus are detected by 
retinoic acid inducible gene (RIG)-like receptors (RLRs) and melanoma differentiation-
associated gene 5 (MDA-5) [99, 100]. All Toll-like receptors and nucleic acid sensors 
activate intracellular signaling cascade that leads to the induction of pro-inflammatory 
cytokines such as IL-8, RANTES and IL-1β [101] and type I IFNs (IFNα and IFNβ) 
promoting antimicrobicidal functions and inflammations. [102]. Table showing PRRs and 
HSV-1 are shown in table 1.2.[103]. IFNα and IFNβ are responsible for the activation of 
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the Jak/STAT pathway which leads to the expression of ISGs (Interferon Stimulated 
Genes) that encode antiviral factors. Inflammasomes are activated by herpes viruses 
leading to the activity of caspase-1. AIM2 (An interferon-inducible protein, absent in 
melanoma 2) act as sensor of viral genomes in the cytoplasm leading to caspase-1 
activation [104] and interacts with apoptosis-associated speck-like protein containing a 
CARD (Capsase Recruitment Domain) recruiting pro-caspase-1, followed by production 
of active caspase-1 and mature IL-1β and IL-18.  
Life cycle of HSV-1 
HSV-1 enter cells by membrane fusion between viral and cell membrane. Viral proteins 
gB or gC interact with heparan sulfate proteoglycans (HSPGs) present on the filopodia of 
cells [105]. It has been shown that cells lacking HSPGs, can get infected through another 
receptor called paired immunoglobulin like type 2 receptor alpha (PILRα) through gB 
envelop protein [106]. When PILRα is expressed on Chinese hamster ovary (CHO) cells, 
viral entry happens through fusion at the plasma membrane. On the other hand, entry 
happened through endocytosis when CHO cells are expressing nectin1 or herpesvirus 
entry mediator (HVEM) [107, 108]. In human cells, changes happen in the cytoskeleton 
for facilitating viral entry through cdc42 (Cell Division Control Protein 42)[109], FAK-1 
(Focal Adhesion Kinase) [110] and phosphoinositide 3 kinase [111].  
Glycoprotein D of herpes virus interacts with three different families of cellular receptors 
and this interaction determines the tropism of the virus as well as the fusion mechanism. 
HVEM helps in entry apart from its role in apoptosis through the tumor necrosis factor 
(TNFR) [112]. Other receptors include nectin-1 and nectin-2, which are the  members  of 
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Table 1.2: Herpes Simplex Type-1 associated pathogen associated molecular patterns 
(PAMPS) and the corresponding pathogen recognizing receptors (PRRS) 
 
 
Pathogen Recognizing Receptors (PRRs) 
 
Pathogen (HSV-1) associated molecular patterns 
(PAMPs) 
TLR2 Viral component and dsRNA 
TLR7 Genomic DNA 
TLR9 Endocytosed DNA 
MDA5 Replication intermediate and Genomic DNA 
                        Pol III / RIG-I 
 
Genomic DNA 
IFI16 Genomic DNA 
 
immunoglobulin (Ig) family, and 3-O sulfated heparan sulfate (3-OS-HS), a 
polysaccharide belonging to the Heparan Sulphate family [113]. Nectins are 
transmembrane proteins abundantly found on nervous system [114] and interacts through 
afadin with actin, thus functions in intercellular adhesion system found in synaptic as 
well as adherens junctions [115]. Receptors used by virus depend on the type of the 
uninfected susceptible cells. For example, entering epithelial cells nectin-1 is preferred by 
the virus [116], while for T lymphocytes HVEM is the major receptor. Interaction with 
receptors acts like a catalyst [117] triggering conformational changes and ultimately 
causing fusion with the help of envelop proteins gB and gH/gL. During fusion 
“hemifusion intermediate”  is formed by the mixing of lipids as well as the  membranes 
of  the cell and virus, ultimately forming a  fusion pore  allowing mixing of cytoplasmic  
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content of cell with viral contents leading to the entry of nucleocapsids with tegument 
proteins into the cytoplasm of the cell [118].  Of all proteins involved, gB is the 
membrane fusogen and most conserved among viral membrane proteins involved in entry 
[119]. Interactions have been demonstrated between gD:gH/gL, gD:gB, gH/gL:gB [120-
122]. Multinucleated cells or syncytia are produced when all the four glycoproteins were 
expressed together in COS cells and syncytial formation failed when only one or two 
proteins were expressed [123, 124]. Another major pathway for HSV entry into HeLa and 
CHO-K1 cell lines is by endocytosis  and this can be prevented by reagents that increase 
endosomal pH, indicating the importance of passage through acidic compartments [125]. 
After endocytosis of enveloped viruses, fusion between viral and cellular membranes 
leads to release of the nucleocapsid into the cytoplasm. Whatever be the route of entry, 
tegument protein VP16 promotes transcription of immediate early or α viral genes 
leading to a cascade of activation leading to transcription of early or β genes and finally 
those β genes products helps in viral DNA replication as well as activate the late or γ 
genes which encode viral structural proteins [126]. ICP0, 4, 22 and 27 are the α viral 
proteins responsible for the transcription herpes genome. In some cases ICP4 has been 
shown to have a negative effect on transcription of genes [127]. ICP22 functions along 
with virus associated protein kinase UL13 by influencing phosphorylation and affecting 
RNA polymerase II functions [128]. ICP27 may also associate with RNA polymerase II 
and influence its functions [129]. Virion host shut-off (Vhs) is a tegument protein, which 
has RNase or RNAase component in association with the translation initiation factor 
eIF4H, which chew off the cellular mRNAs and thus favor expression of viral transcripts 
[130]. DNA viruses including herpes viruses replicates in the subnuclear structures called 
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ND10 [131] and cause disruption of ND10, which may enhance viral 
transcription/replication by making use of its components or to prevent its negative effect 
on viral lifecycle. ICP0 is acts as a promiscuous transactivator and it separates HDACs 1 
and 2 from the CoREST/REST repressor complex, thus prevents viral DNA silencing 
[132]. There is circularization of linear genome of herpes virus within 30 minutes of 
entry to cells [133] . Spread of infection to susceptible neighboring cells happens through 
virus released to infected cells or through direct cell-to cell spread [134]. During egress 
the virus nucleocapsid first acquires tegument proteins and then envelope. The most 
supported school of thought is the envelopment-de-envelopment theory put forward by 
Stackpole [135]. The herpes virion morphogenesis and egress occurs through a complex 
mechanism characterized by: a) primary envelopment of capsids at the inner nuclear 
membrane; b) de-envelopment of them at the outer nuclear membrane; c) cytoplasmic 
capsids acquire sets of tegument proteins; d) re-envelopment of tegumented capsids into 
TGN-derived membranes [1]. 
Transport and Egress of HSV-1 
 
If the transport is only through diffusion, HSV-1 capsid could take around 230 years to 
move just 1 cm through cytoplasm [136]. However in the case of in vitro infection of 
cultured cells, capsids may move by diffusion to reach nucleus since at the apical surface 
it lies very close to cytoplasm [137]. On the other hand virus will be adopting more 
sophisticated transport mechanism for traveling through long sensory neurons during its 
life cycle. For the transport of cargos like organelles or vesicles, cells make use of 
microtubules and motor proteins like kinesin or dynein.  
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Microtubules are made of alphabeta-tubulin heterodimers. Dynein motors move cargos 
from minus end of microtubule towards the nucleus to microtubule organizing center 
(MTOC), whereas kinesin motors transport cargos towards periphery that is to the plus-
ends of the microtubules [138].  Viruses encode only limited number of proteins required 
to complete its life cycle since their genomes are small. So they make use of cellular 
mechanisms for their own benefit.  The size of dynein is Mr 1.2 x 106 and is made of 
heavy chains, intermediate chains, light intermediate chains and light chains. The 
different combinations of the light and intermediate chains decide the specificity of cargo 
binding [139]. Dynactin is a co-factor of dynein which regulates its functions [140]. The 
retrograde transport of capsids requires microtubular network and the transport is 
disrupted by microtubular inhibitors like colchicine, vinblastine, or nocodazole [141]. 
Speed for retrograde transport is roughly 200±300 mm/day in animals and 3±5 mm/h in 
culture [142, 143]. 
 
The viral protein first shown to bind with dynein was pUL34 [144] and the capsid protein 
VP26 (pUL35) is important for retrograde transport of virus [145]. Proteins predicted to 
interact with dynein are in the inner tegument or outer capsid. For example capsid protein 
pUL35 (VP26) has been shown to interact with dynein through colocalization by 
microinjecting recombinant capsids into live cells and transport of capsids towards 
nucleus [145]. Dystonin is a cytoskeletal linker protein present at the plus end and 
function in both retrograde as well as anterograde transport in neurons. Travel to the 
centrosome by capsid is through minus-ended transport while further towards nucleus is 
by plus-ended transport. Depletion of dystonin did not affect the transport of capsid to the 
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centrosome, but had a deleterious effect on further transport towards nucleus [146].  
Same group have also shown that dystonin interacts with herpes tegument protein pUL37 
and is indispensable for efficient egress of capsids [147]. Membrane glycoprotein gK is 
required throughout the life cycle of the virus from entry to egress [148].  An in vitro 
transport study in neurons using microfluidic device showed that  gK is essential for  
infection of neuronal axons, may be due to lack of regulatory role of gK on gB during 
entry process caused by the fusion between viral membrane with axonal synaptic 
membrane [8]. Anterograde transport refers to transport from the neuronal cell body to 
axons and there are models proposed for herpes virus anterograde transport through 
neurons. In cultured sensory neurons newly formed capsids are moving in both directions 
with a net movement towards the plus-end direction [149]. In separate model, naked 
nucleocapsids devoid of any membrane proteins are transported down the axons, whereas 
in the married model complete virions together with the membrane proteins are 
transported [150]. Brefeldin-A (BFA) is a chemical which can cause disruption of Golgi 
apparatus and thus affect egress by interfering assembly of virions [151]. A study has 
shown that BFA caused inhibition in the anterograde transport of glycoproteins and had 
no effect in the transport of nucleocapsids supporting the separate model [152]. Whereas, 
transmission electron microscopic images of the proximal and mid-axons of primary 
superior cervical ganglion (SCG) neurons showed that complete virions were present in 
case of HSV-1 NS and 17, HSV-2 2.12 and PRV Becker infections supporting the 
married model for transport [153]. On the contrary, another group has supported the 
separate model of anterograde transport by showing in HSV infected murine retinal 
ganglion cell model that US9 is necessary for the efficient anterograde transport 
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specifically of viral capsid and DNA, but not required for the viral envelope 
glycoproteins anterograde transport [154]. UL36 (VP1/2) encodes the largest HSV1 
tegument protein having a molecular weight of 273 kDa and has been shown to be 
important for binding to microtubule and also transport down the axon [155]. Motors that 
function in transporting cargoes from inside to plus end of microtubules located at the 
periphery of cells are kinesins [156] and make use of energy from ATP for 
conformational changes to generate motile force [157]. Kinesin protein superfamily 
consist of 15 members named kinesin 1 to kinesin 14 B. First kinesin discovered is the 
tetrameric Kinesin 1 [158], made of  two identical light chains of Mr 64000 and two 
identical heavy chains of Mr 120000 [159]. Based on the location of the motor domain 
they are classified into three types; N-kinesins, M-kinesins and C-kinesins if motor 
domain is in the amino-terminal, middle or carboxyl-terminal region of the protein 
respectively. N-kinesins and C-kinesins are involved in the microtubule plus and minus 
end transport, whereas M-kinesins depolymerize microtubules. For anterograde transport 
cell make use of N-kinesins and for retrograde transport other than dynein, C-kinesins 
can also help [156]. In polarized non-neuronal cells, enveloped complete viruses are 
transported from the Golgi network to cell surface [160, 161]. Interaction has been 
demonstrated between viral proteins and proteins of cell important for secretory and 
exocytosis pathways in neurons like TGN-46 (marker protein of trans-Golgi network), 
Kinesin-1, GAP-43 (neuron-specific protein), Rab3A (regulatory protein in intracellular 
trafficking), and SNAP-25 (Q-SNARE protein) [162].  
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gK/UL20 Role in Envelopment and Egress 
HSV-1 nucleocapsid in the cytoplasm acquires envelop by budding into trans-Golgi 
network (TGN)-derived membranes. The two important membrane associated proteins at 
the TGN are picked up by the virus at the TGN. Mature viruses depend on cellular 
secretory pathway to be transported to cell surface to egress [1]. Genes shown to be 
important for secondary envelopment are PrV gB [163], HSV-1 gK, UL20p, gE, gM, gD, 
UL11, UL48 [164-169], and PRV US3 [170]. gK/UL20 proteins were found to be the 
most vital components for cytoplasmic virion envelopment, egress and infectious virus 
production when compared to  gM, gD, UL11, and gE [2].  gK and UL20p have multiple 
membrane spanning domains and are highly conserved among the members of 
alphaherpesviruses [171]. gK is made of 338 amino acids and UL20p is made of 222 
amino acids. Interactions between membrane and tegument proteins are required for 
proper envelopment and egress and this may be affected in gK/UL20 mutant virus 
causing problems in secondary envelopment.  Studies have also shown that UL20p in 
PRV functions in cell-cell spread and egress form infected cells. Electron micrographs 
showed that in UL20p mutant PrV virus, there was accumulation of enveloped viral 
particles in the cytoplasmic vesicles of Vero cells. This observation is different in HSV-1 
since deletion of UL20p caused accumulation in the perinuclear space of infected Vero 
cells [172]. These observations point out the fact the UL20p function definitely in egress 
but may be at different step during the process. Similarly HSV-1 gK was also shown to 
be  important for regulation of egress of new virion particle from cells since the HSV-1 
mutant F-gKβ lacking gK protein causes accumulation of enveloped and unenveloped 
virus particles in the cytoplasm of cells [173]. Apart from cellular viral envelopment and 
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egress, the two proteins of HSV-1 gK and UL20p are important for virus-induced cell 
fusion and mutations in either genes can cause extensive fusion between cells forming 
syncytia [174-176]. There were different experimental results suggesting the 
interdependence of gK and UL20p to function together indicating a physical and 
functional interaction between them. Confocal colocalization experiments showed that 
both proteins are essential for transport within cells, cell surface expression, cell induced 
fusion and cytoplasmic envelopment and egress [177-179]. The predicted structures of 
the proteins are mirror images of each other with amino and carboxyl termini of gK 
facing extracellular region while that of UL20p facing intracellular. Immunoprecipitation 
and western blot have demonstrated the physical interaction between gK and UL20p and 
most specifically between cytoplasmic domain III of gK and amino-terminal of UL20p 
[180]. The role of gK /UL20p in nuclear egress is not suspected as retention of UL20p 
resulted in accumulation of nucleocapsids in the cytoplasm of cells [174].  
Membrane Proteins of HSV-1 
UL20 Protein/ Glycoprotein K (UL20/gk) 
UL20p is a structural protein made of 222 amino-acids which is non-glycosylated and has 
transmembrane domains. In infected cells distribution of the protein is mainly perinuclear 
and cytoplasmic [181]. Glycoprotein K (gK) like UL20p has multiple transmembrane 
regions and is made of 338 amino acids encoded by the UL53 open reading frame. The 
protein has two potential sites for N glycosylation and has a 30-amino acid long cleavable 
signal sequence at the amino terminal [182]. Among alpha herpesviruses like HSV-1, 
PrV, and varicella-zoster virus, gK mutant virus showed a defect in virion envelopment 
and egress.  
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Both gK as well as UL20p is highly conserved among all alphaherpesviruses [183, 184]. 
The structures of gK/UL20p were predicted based on the results of experiments which 
tagged the suspected intracellular and extracellular domains with epitopes [5, 176]. gk 
plays a role in viral fusion since gBΔsyn28 mutation, which is known to cause extensive 
virus-induced cell fusion, was inhibited in absence of amino terminus of gK (gKΔ31-68 
mutation) pointing out the interdependence and interaction between gK and gB [5]. 
Mutation of UL20 gene by deletion has resulted in weakly syncytial plaques in some cell 
lines and also affected proper envelopment showing the importance of gene with regard 
to cell fusion and virion morphogenesis [176]. So the role of both genes in virus-induced 
cell fusion was shown by proving the protein-protein interaction between UL20p and 
amino terminus of gK with gB in infected cells [185]. 
Studies have found that UL20 null virus accumulate in the space between nuclear 
membranes in certain types of cells like Vero and HEp-2. However, in the case of 143TK   
cells virions reach the cytoplasm. This phenomenon depended upon the presence or 
absence of intact Golgi networks. Cells complemented UL20-null virus was able to 
maintain intact Golgi network, while the network in those that failed in complementation 
were fragmented and dispersed [186]. The role of UL20p in fusion is reiterated by the 
absence of fusion event in syncytial mutants of gB or gK [179] and also UL20p is 
required for cell surface expression of gK [177-179]. Deletion of UL20 or lethal UL20 
mutations affects envelopment and leads to accumulation of a few completely enveloped 
capsids in the cytoplasmic vesicles and also unenveloped capsids in the cytoplasm of 
infected cells [172, 179].   
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cytoplasmic virion envelopment and egress. When single, double or triple mutant viruses 
were generated deleting these membrane proteins, the most defective ones in terms of 
cytoplasmic envelopment, egress, and production of infective viruses were the mutants 
with deletion of gK or UL20p [2].  There are other herpes proteins with which UL20p 
interact and functions in various steps in the life-cycle of the virus. Apart from its role in 
egress and envelopment, UL20p can also modulate virus-induced fusion since the protein 
can physically interact with major fusogenic protein gB as proved by two-way 
immunoprecipitation studies [185]. UL20p pairs with another important membrane 
glycoprotein gK and this is supported by the lack of cell surface expression of gK as well 
as cellular fusion mediated by gK in UL20-null mutant virus infected cells [179]. 
Colocalization of the proteins in confocal microscopy showed the proteins were 
interdependent for intracellular transport, cell surface expression and localization at the 
TGN, virus-induced cell fusion, and cytoplasmic virion envelopment [176-179]. The 
physical interaction between them most likely is between-terminal portion of UL20p with 
cytoplasmic gK domain III and has been shown through glutathione S-transferase (GST) 
pull down experiments and reciprocal coimmunoprecipitation method. It was also shown 
that retention of UL20p in the ER leads to retention of gK pointing out that may be their 
transport is interdependent on each other and also UL20p retention prevents cytoplasmic 
virion envelopment and virus-induced cell fusion [180]. Studies showed that proteins 
UL20p and UL11 are transported independently to TGN, but UL20p functions precedes 
and are required for UL11 function in the cytoplasmic virion envelopment [187]. 
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Glycoprotein B (gB) 
The most highly conserved protein in the core fusion machinery among all herpes viruses 
is glycoprotein B (gB) and the crystal structure reiterates the fusogenic character of the 
protein [119].  The protein is made of 904 amino acids [188]. In addition to binding with 
heparin and heparan sulfate, paired immunoglobulin-like type 2 receptor (PILRα) can 
function as a  receptor for gB  for viral entry as well as for fusion, but the glycoprotein D 
should also bind to its respective receptor [106, 189]. There is a 30-amino acid residue N-
terminal signal sequence which is cleaved during processing, external domain made of a 
743-residue, transmembrane domain of  22 amino acids and a 109-residue cytoplasmic 
domain [188, 190]. There is structural similarity with fusion proteins of vesicular 
stomatitis virus (VSV) G and baculovirus gp64 [191, 192]. In case of Epstein-Barr virus 
(EBV) protease cleavage is required to activate the protein, but in case of HSV this has 
not yet been proved [193]. It is believed that low pH in the endosomes may be helping gB 
in reaching the fusogenic form in HSV [194]. 
Glycoprotein C (gC) 
In HSV-1 gC play an important role in attaching to its receptor heparan sulfate (HS) and 
chondroitin sulfate (CS) [195, 196]. Open reading frame of gC is made of 511 amino 
acids with a hydrophobic signal sequence, a hydrophobic membrane anchoring sequence 
and has 9 sites for N-linked glycosylation [197]. Molecular weight of gC calculated by 
SDS-PAGE is around 130kD, but from amino acid sequence is only 55kD and this 
difference is due to N-linked oligosaccharides [198], and O-linked oligosaccharides 
[199]. This heavy glycosylation is important for the protein to act as the receptor for the 
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 complement factor c3b [200].  It was shown that the protein requirement in the life-cycle 
of HSV-1 is dependent on cell types, as gC is not essential for binding of virus to Vero 
cells and its replication was similar to wild-type in Vero, BHK and epithelial cells [201], 
whereas in case of mammalian neurons lack of gC reduced efficiency in replication to 5-
10 fold when compared to wild-type [202].  gC can act as an immune modulator by 
inhibiting complement cascade by binding to C3b, a pivotal component of classical and 
the alternative complement pathways [203] and preventing binding of C5 and properdin 
to C3b [204].   
Glycoprotein D (gD) 
gD is a type I integral membrane glycoprotein made of 394 amino acids and cleaving of a 
signal peptide of 25 amino acids during processing yield a mature protein of 369 amino 
acids [205]. There are 3 sites for N-linked glycosylation [205, 206], o-linked 
oligosaccharides [207] and a hydrophobic transmembrane anchor sequence near the 
carboxy terminus [208, 209]. Several labs were able to show that gD can act as a ligand 
for HSV receptor. For instance, inactivated wild-type virions blocked infection with 
HSV, but UV-inactivated virions lacking gD failed in inhibiting infection [210]. Then 
scientists have shown that wild-type HSV failed to infect gD expressing cells [211]. This 
inhibition is based on the structure of the protein in the infecting virus and occurs during 
the step of penetration [212-214]. Finally, infection is prevented when cells are incubated 
in the presence of soluble truncated gD [215-217]. Native conformation is critical for gD 
function and is not dependent on the three N-glycosylation [218-220]. Cell surface has 
many receptors for gD for allowing entry of HSV [221].  
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The herpesvirus entry mediator (HVEM), the first herpes receptor found is a member of 
Tumor Necrosis Factor Receptor (TNFR) family and is used by both type 1 and type 2 of 
HSV [222]. HVEM has low levels of expression on fibroblasts and on ocular tissue [223, 
224]. Whereas, Nectin-1 receptor is for both type 1 and 2 on neurons are present on 
keratinocytes, and epithelial cells [224]. Heparan sulfate (HS) modified by 3-O-
sulfotransferases (3-OS-HS) can also act as a receptor for gD [225].  
Glycoprotein G (gG) 
US4 gene made of 716 bp encodes 238 aa glycoprotein G (gG). The function of 
glycoprotein G has been a difficult task to explore. Studies have shown that mutations in 
the gene whether deletion or insertions did not affect the replication of virus in 
nonpolarized cells [226, 227].Whereas, in case of polarized cells viral gG is required for 
efficient infection of apical membranes of the cells and gG deleted mutant infected basal 
membranes similar to wild-type virus. The first surface virus getting exposed is the apical 
membranes of epithelial cells on the mucosal surface of the susceptible host. On the other 
hand, scarification of corneas allowed viral exposure to other cell surface and gG deleted 
virus could infect as similar to wild-type virus [228]. 
Glycoprotein E and I (gE/gI) 
gE/gI is a heterodimer and have extracellular portions and cytoplasmic regions made of 
100 amino acids have tyrosine motifs, dileucine, acidic clusters which may tend to 
localize the protein in the trans-Golgi network [229, 230]. gE and gI are found bound to 
each other and formation of a heterodimer happen quickly and they function as a complex 
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 [231, 232]. The protein complex has a very important role to play with regard to spread 
of virus between tight junctions of neighboring cells especially in case of epithelial cells, 
fibroblasts, and neurons. The heterodimer localized on the lateral surfaces of epithelial 
cells, but was absent on both apical and basal surfaces. In case of less confluent cell 
culture monolayers, gE/gI was found at cell junctions but lacked completely on lateral 
cell surfaces which were not in contact with adjacent cells [233].There was spread defects 
in mutant HSV-1 viruses lacking gE or gI in epithelial and neuronal cell cultures [233, 
234]. A study have shown that in corneal cells there was a spread defect of 4 to 6 % on 
epithelial cells when compared to the wild-type HSV virus [235]. Spread among 
susceptible cells is through sorting of new progeny virions to lateral cell surface and cell 
junctions [236]. In an experiment when the entire gE protein or the cytoplasmic (CT) 
domain of the protein was deleted caused accumulation of virions in the cytoplasm, at the 
apical surfaces, and also in cell cultural supernatants whereas  in case of wild-type virus 
accumulation was concentrating at cell junction. This showed the importance of 
cytoplasmic domain of gE protein in cell-cell viral spread [237]. Apart from spread the 
heterodimer functions include immune evasion and virulence [238-240].  
Glycoproteins H and L (gH/gL) 
The most important glycoproteins for viral entry and fusion among herpesviruses other 
than gB and gD are glycoprotein H (gH) and L (gL). Both gH and gL are required for 
posttranslational modifications and transport. Studies have shown that if only gH is 
expressed, then the protein processing is affected and the misfolded protein is trapped 
intracellulary [241]. Similarly, for proper expressions and posttranslational modifications 
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 of gL is dependent on gH. Since gL lacks any hydrophobic domain to act as a membrane 
anchor, the association with gH may be helping the protein to remain membrane 
associated [242]. Another school of thought is that the hydrophobic amino terminus act as 
a membrane anchor and also as a signal peptide. gH is a type 1 membrane protein with 
the signal sequence directing it to the biosynthetic pathway and the transmembrane 
domain of the protein helps in attaching gH/gL protein complex to the membrane [243].  
There have been emphasis on specific amino acids on the cytoplasmic domain of gH 
required for membrane fusion [244]. Antibodies to gH inhibited both cellular spread and 
virus infectivity [245], while antibodies to gL only affected cellular fusion and not virion 
infectivity [246]. Neutralizing antibodies were made when mice were vaccinated with 
gH/gL complex and the vaccinated group showed less primary infections and upon 
challenge there were no secondary lesions [247].  
Glycoprotein J (gJ) 
 
Glycoprotein J is encoded by US5 gene and their major function is in the ability to inhibit 
apoptosis [248]. It was in 1998 the ability of US9 genes sequence to encode gJ was 
demonstrated [249].  Soon it was shown that the us9 deletion abolished UV- or anti-fas-
induced apoptosis [79]. The gene is initially expressed 4h after infection and can be 
detected at 6 h after infection. There are two forms, glycosylated and unglycosylated. The 
distribution was bound to endoplasmic reticulum, trans-Golgi network and early 
endosomes. Further works were able to show that just the expression of gJ  can protect 
infected cells from apoptosis induced by cytotoxic T lymphocyte killing mechanism 
[248]. The protein is produced in limited quantities and localizes to membranes in the 
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cells. gJ can produce reactive oxygen species (ROS) in transfected and infected cells and 
may be influencing HSV lifecycle in different ways [250]. 
Glycoprotein M (gM) 
 
The glycoprotein M (gM) is a hydrophobic type III membrane protein of 475 amino acids 
encoded by the UL10 gene. It has eight transmembrane domains with amino and carboxy 
termini directed towards cytosol [251, 252]. The open reading frame of the gene has two 
sites for N-linked glycosylation, one at the amino acid position 71 and the other at amino 
acid position 247. The first site is conserved among homologs of the gene in human 
cytomegalo virus (CMV) and varicella-zoster virus [253]. gM localizes to ER in infected 
cells [254].  The protein is highly hydrophobic and aggregates when boiled with buffers 
having SDS similar to UL20 protein [165, 251]. gM has also shown moderate 
antagonistic activity against tetherin, an antiviral effector that tethers newly enveloped 
virions to cell membrane preventing the egress [255]. Even though the gene is highly 
conserved among the members of family herpesviridae, it is a non-essential gene for 
HSV-1 [256], pseudorabies virus (PRV) [257], bovine herpes virus type 1 [258], 
Varicella-zoster virus [259], infectious laryngotracheitis virus [260], equine herpes virus 
type-1 (EHV-1) [261], and EHV type 4 [262]. In HSV-1, deletion of gM leads to small 
reduction in viral replication titers and smaller plaque sizes [169, 256]. gM can redirect 
other glycoproteins like gD and gH/gL to TGN following transfection due to the presence 
of classical endocytic signals at the carboxyl terminus [263]. Interaction between gM and 
VP22 encoded by UL49 has also been demonstrated [264]. gM can also associate with 
another membrane glycoprotein gN in various herpes viruses [265-268].  
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Glycoprotein N (UL49.5) 
 
The open reading frames of HSV-1 and HSV-2 UL 49.5 is comprised of 91 and 87 
codons respectively and protein has a transmembrane domains and expressed from a Y2 
transcript [269, 270]. In case of PrV UL49.5 protein is made of 98 amino acids with the 
molecular weight around 10 kDa and have a signal peptide. The molecular mass will be 
reduced by 2 kDa if the signal sequence is cleaved. In HSV-1 the UL49.5 gene is 
separated from UL50 by 23 bp. This gene is conserved in Varicella zoster virus (VZV) 
[271].  
Tegument Proteins 
Initially HSV-1 virion proteins including tegument proteins were named viral protein 1 
(VP1) to viral protein 24 (VP24) on the criteria of migration on a denaturing protein gel 
[272, 273]. Later tegument proteins were named based on the open reading frames and 
are called unique short (US) or unique long (UL) with prefix p in order to distinguish 
between a protein and a gene. The total number of tegument proteins determined by 
proteomic analysis in HSV-1 is 23 [274]. Some of the tegument proteins like pUL46 
(VP11/12), pUL47 (VP13/14), pUL48 (VP16), and pUL49 (VP22) are abundantly 
present with copy numbers ranging from 1000-2000 copies. The four tegument proteins 
critical for viral growth in cell lines are pUL36 (VP1/2), pUL37, pUL48 and ICP4 [275]. 
During entry of virus to nonneuronal cells most of the envelop as well as tegument 
proteins are lost and nucleocapsids with a few inner tegument proteins reach host cell 
nucleus [276, 277].  It has been confirmed that the inner tegument proteins pUL36 and 
pUL37 are conserved among the herpesviridae family and associated with capsids after 
entry to Vero cells [278]. The incoming HSV-1 nucleocapsids depend on microtubular 
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transport based on dynein/dynactin complex to reach nucleus. The most suspected 
candidates for interacting with dynein motor proteins are pUL36 and pUL37, though 
nobody has yet proved through experiments [279]. Multiple studies have shown the 
importance of pUL36 in directing nucleocapsids to the nuclear pore complex (NPC) for 
the release of viral DNA [280-282].  Another tegument protein pUL14 has also been 
shown in targeting capsids to the nucleus [283]. pUL48 plays role in the formation of 
transcriptional complex and for formation of new virions [284]. Virion host shut-off (vhs) 
proteins (pUL41) inhibit both host and viral protein synthesis by degrading mRNA [285]. 
pUS11 binds to dsRNA through RXP repeats and interacts with nucleoli and ribosomes 
[286] and inhibit cellular protein synthesis through regulation of protein kinase R-
activated host protein shutoff and decay of mRNA [287]. For envelopment and egress, 
virions require both pUL36 and pUL37 which are conserved among members of 
Herpesviridae family [288].  Both these proteins along with pUS3 forms the inner 
tegument layer of the newly formed nucleocapsids in the cytoplasm [289]. It has been 
shown that transport of pUL37 to golgi is affected in the absence of pUL36 in a capsid-
independent manner [290]. It has been shown that pUL37 is only essential for replication 
of HSV-1, whereas in PrV they require both proteins UL36 and UL37.  
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CHAPTER III 
PHENYLALANINE RESIDUES AT THE CARBOXYL-TERMINUS OF THE    
HERPES SIMPLEX VIRUS TYPE-1 UL20 MEMBRANE PROTEIN 
REGULATE CYTOPLASMIC VIRION ENVELOPMENT AND 
INFECTIOUS VIRUS 1 PRODUCTION 
 
Importance 
The herpes simplex virus type-1 (HSV-1) UL20 gene encodes a 222 amino acid long 
non-glycosylated envelope protein which forms a complex with viral glycoprotein K 
(gK) that functions in virion envelopment, egress, and virus-induced cell fusion. To 
investigate the role of the carboxyl-terminus of the UL20 protein (UL20p) in cytoplasmic 
virion envelopment, a cadre of mutant viruses was constructed and characterized.  
Deletion of six amino acids from the carboxyl terminus of UL20p caused approximately 
one-log reduction in infectious virus production compared to the wild-type virus. 
Surprisingly, a phenylalanine-to-alanine replacement at amino acid position 210 caused a 
gain-of-function phenotype increasing infectious virus production up to one log more 
than the wild-type virus. In contrast, replacement of two membrane proximal 
phenylalanines with alanines caused drastic inhibition of infectious virion production and 
cytoplasmic virion envelopment. Prediction of the membrane topology of UL20p 
revealed that these two amino acid changes cause retraction of the carboxyl-terminus of 
UL20p from the intracellular space. Confocal microscopy revealed that all the engineered 
UL20 mutations did not affect intracellular transport of UL20p to trans-Golgi Network 
membranes. 
                                                            
1 This chapter previously appeared as Charles et al., 2014. Phenylalanine residues at the carboxyl-terminus 
of the Herpes Simplex Virus type-1 UL20 membrane regulate cytoplasmic virion envelopment and and 
infectious virus production. J Virol. 2014 Jul 1;88(13):7618-27. It is reprinted with the permission of 
American Society of Microbiology. 
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 In addition, proximity ligation assay showed that none of the UL20 mutations affected 
UL20p colocalization and potential interactions with the UL37 protein recently found to 
interact with the gK/UL20 protein complex. Collectively, these studies show that 
phenylalanine residues within the carboxyl terminus of UL20p are involved in the 
regulation of cytoplasmic virion envelopment and infectious virus production. 
We have shown that the UL20/gK protein complex serves crucial roles in cytoplasmic 
virion envelopment and that it interacts with the UL37 tegument protein to facilitate 
cytoplasmic virion envelopment. In this manuscript, we investigated the role of 
phenylalanine residues within the carboxyl terminus of UL20p, since aromatic and 
hydrophobic amino acids are known to be involved in protein-protein interactions 
through stacking of their aromatic structures.  Characterization of mutant viruses carrying 
phenylanine (phe) to alanine (ala) mutations revealed that the two membrane proximal 
phe residues were critical for the proper UL20p membrane topology, and efficient virion 
envelopment and infectious virus production.  Surprisingly, a phe-to-ala change located 
approximately in the middle of the UL20p carboxyl terminus substantially enhanced 
cytoplasmic envelopment and overall production of infectious virions. This work 
revealed that phe residues within the UL20p carboxyl terminus are involved in the 
regulation of cytoplasmic virion envelopment and infectious virus production. 
Introduction 
Herpes Simplex Virus type 1 (HSV-1) is a neurotropic herpes virus that after replication 
in epithelial cells enters into ganglionic neurons via distal axons and establishes latent 
infection [1]. HSV-1 is the primary infectious cause of blindness in the western 
hemisphere primarily because periodic reactivation causes recurrent keratitis and scarring 
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of cornea [2, 3]. Herpes virus particles consist of a linear double-stranded DNA genome 
containing an icosahedral capsid, surrounded by a proteinaceous tegument, and an 
outermost cell-derived lipid envelope. The virus encodes at least eleven glycosylated and 
several non-glycosylated proteins expressed on the viral envelope and in infected cell 
membranes, which are important for the life cycle of the virus especially during virus 
entry, intracellular virion morphogenesis and cell-to-cell spread. HSV-1 virion 
morphogenesis and egress involves complex mechanisms, which are characterized by 
sequential morphogenetic steps including: a) primary envelopment of capsids at the inner 
nuclear membrane; b) de-envelopment of enveloped capsids at the outer nuclear 
membrane; c) acquisition of tegument proteins in the cytoplasm of infected cells; d) re-
envelopment of tegumented capsids at the TGN-derived membranes [4-6]. Cytoplasmic 
virion envelopment is facilitated by multiple interactions among viral glycoproteins 
embedded in TGN membranes and tegument proteins [6-10].  
The UL20 gene encodes a 222 amino acid long non-glycosylated envelope protein, which 
plays a crucial role in cytoplasmic virion envelopment and egress of HSV-1. The UL20 
gene is highly conserved among alphaherpesviruses including varicella-zoster [11], 
pseudorabies virus (PRV) [12] and the gammaherpesvirus Marek's disease virus type 2 
[13]. The UL20 protein has been shown to be important for infectious virion production 
for both PRV and HSV-1 [14, 15]. The UL20 protein forms a functional complex with 
glycoprotein K (gK), which physically binds with gB and gH to modulate virus-induced 
cell fusion [16].  
Deletion of 18 amino acids from the carboxyl terminus of UL20p (UL20 mutant virus 
204t) inhibited intracellular transport and cell surface expression of both gK and UL20p, 
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and failed to complement infectious virus production. On the other hand, deletion of 
either 6 (UL20 216t) or 11 amino acids (UL20 211t) allowed efficient UL20p and gK 
intracellular transport and cell surface expression, but failed to complement for infectious 
virus production [17]. Phenylalanine residues are aromatic and hydrophobic amino acids 
that are known to be involved in protein-protein interactions and have been shown to play 
an important role in respiratory syncytial virus assembly [18]. Therefore, we sought to 
determine the potential role of phenylalanine residues in the carboxyl terminus of UL20p 
in cytoplasmic virion envelopment and egress under the hypothesis that cytoplasmic 
domains of UL20p may interact with tegument proteins to facilitate cytoplasmic virion 
envelopment. The UL37 protein is a 120 kDa phosphorylated protein [19] that assumes a 
predominantly diffused cytoplasmic distribution in infected cells [20-22] and can be 
transported to TGN membranes as a complex with the UL36 protein in the absence of 
capsid formation [23]. The UL37 tegument protein specified by HSV-1 and PRV has 
been shown to play an important role in cytoplasmic virion envelopment, since deletion 
of the UL37 gene resulted in accumulation of capsids in the cytoplasm of infected cells 
[24-26]. Recently, we showed that the HSV-1 UL37 protein interacts with gK and UL20p 
to facilitate cytoplasmic virion envelopment [27]. Herein, we show that a UL20 
phenylalanine residue at position 210 plays a critical regulatory function in cytoplasmic 
virion envelopment and infectious virus production, as evidenced by the surprising one 
log higher infectious virus production of the mutant virus containing a phe to ala 
substitution at aa residue 210, when compared to wild-type virus. Moreover, two other 
phenylalanine residues proximal to the membrane of the carboxyl-terminus of UL20p are 
required for proper UL20p membrane topography and function.  These phenyalanine to 
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alanine mutations did not appreciably alter the co-localization and potential interactions 
with the UL37 protein suggesting that they do not play major roles in the overall 
interactions between the UL37 protein and the gK/UL20 protein complex. 
Materials and Methods 
Cells. 
African green monkey kidney (Vero) cells were obtained from the American Type 
Culture Collection (Rockville, MD) and Vero based UL20 Protein complementing FRT 
Cells were maintained in Dulbecco's modified Eagle's medium (Gibco-BRL; Grand 
Island, N.Y.) supplemented with 10% fetal calf serum and antibiotics.  
Construction of HSV-1 mutant viruses 
Mutagenesis was accomplished in Escherichia coli using the markerless two-step Red 
recombination mutagenesis system and synthetic oligonucleotides [28, 29] implemented 
on the bacterial artificial chromosome (BAC) plasmid pYEbac102-VC1 carrying the 
HSV-1(F) genome with proteins gK and UL20 tagged with V5 and 3xFLAG antigenic 
epitopes, respectively. Unless otherwise specified, the wild-type virus used in all 
experiments is the VC-1 strain. HSV-1 mutants UL20∆6 and UL20∆Phe were 
constructed by adding a stop codon TAA in front of last amino acid or last 6 amino acids 
from the carboxyl end of UL20p respectively. Whereas, mutants UL20F222A, 
UL20F210A, and UL20F205-206A were created by changing codons for Phenylalanine 
at respective positions to Alanine codon GCA (Table 1). HSV-1 BAC DNAs were 
purified from 50 ml of overnight bacterial cultures with a Qiagen large-construct kit 
(Qiagen; Valencia, CA). Using PCR test primers designed to lie outside the target 
mutation site (s), all mutated DNA regions were sequenced to verify the presence of the 
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desired mutations in BACs. Similarly, viruses recovered from cells transfected with 
BACs [28] were sequenced to confirm the presence of the desired mutations. The entire 
genomes of the wild-type and the UL20F210A mutant viruses were sequenced using the 
Ion Torrent Next Generation Sequencing equipment (Life Technologies-Invitrogen; 
Carlsbad, CA), as we have described previously [30]. Briefly, total genomic DNA 
(gDNA) was extracted from the virus-infected Vero cells using the PureLink Genomic 
DNA Mini Kit (Life Technologies-Invitrogen; Carlsbad, CA). High-quality fragment 
libraries of each virus were prepared from the extracted total gDNAs using the Ion 
Xpress Plus Fragment Library Kit (Life Technologies-Invitrogen; Carlsbad, CA). The 
fragment libraries were subsequently applied to Ion 316 chips and were sequenced on the 
Ion Personal Genome Machine System (Life Technologies-Invitrogen; Carlsbad, CA).   
SDS-PAGE and Western Immunoblot Assay 
Western immunoblot analysis was carried out essentially as described earlier [31]. 
Confluent monolayers of Vero cells were infected with the indicated viruses at an MOI of 
2. At 24 hpi, cells were washed with PBS and lysed on ice for 30 min in NP-40 lysis 
buffer (Life Technologies) supplemented with a cocktail of protease inhibitors (Roche, 
LLC, Basel, Switzerland). The collected samples were mixed with SDS-PAGE sample 
buffer (NuPAGE) at 3:1 ratio and were electrophoretically separated by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (Tris-HEPES-SDS gradient 4-20% gels, 
Thermo scientific). Following electrophoresis, the proteins were transferred onto a 
nitrocellulose membrane under a constant current. Membrane was blocked in Phosphate-
buffered saline containing 0.1% Tween 20 (PBST) plus 5% nonfat milk for 1 hour at 
room temperature (RT) and was probed with primary mouse anti-Flag mAbs (Abcam; 
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Cambridge, England) for over-night at 4°C. Goat anti-mouse secondary antibody 
conjugated with HRP and Immobilon chemiluminescent HRP substrate (Millipore) were 
used for detection purposes.  
Plaque Morphologies, Replication Kinetics and Electron Microscopy. 
For plaque morphology, confluent monolayers of Vero or FRT cells were infected at a 
MOI of 0.001 with the viruses and fixed with methanol 48 h post infection. 
Immunohistochemistry was performed with primary rabbit anti-HSV antibodies (1:1,000) 
(Dako) and goat anti-rabbit horseradish peroxidase-labeled antibody (1:1,000) (Dako), 
and the reactions were developed using the NovaRed substrate (VectorLabs). Images 
were taken with an inverted light microscope (Olympus) using relief contrast. Growth 
kinetics studies of viruses were performed as we have described earlier [32, 33]. 
Approximately 90% confluent Vero cells were infected with each virus at 4°C for 1 hour 
at a low or high multiplicity of infection (MOI) of 0.2 or 2 respectively. Afterwards, 
plates were incubated at 37°C for 1 hour to allow virus penetration. Any remaining 
extracellular viruses were inactivated by low pH treatment using PBS at pH 3 and plates 
were incubated till its time point and subsequently stored at -80°C till the virus titers were 
obtained by endpoint titration on FRT cells. The ultrastructural morphology of virions 
within infected cells was examined by transmission electron microscopy as described 
previously [16, 28, 32, 34].  All flasks with infected cells were incubated at 37°C and 5% 
CO2 until processed at 18 hours post infection (hpi) and infected cell samples were 
visualized by transmission electron microscopy.  
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Quantification of cell-to-cell fusion 
Chemiluminescence-based assay system was used to quantify cellular fusion during viral 
infection [35-37]. Around 80-90 % confluent Vero cells in 12-well plates were 
transfected separately with plasmids expressing T7 polymerase gene or luciferase gene 
under the T7 promoter at amounts 1µg/well each. Lipofectamine 2000 (Invitrogen) was 
used for all transfections. Media was changed six hours post-transfection and after 12 
hours of incubation at 37°C and 5% CO2, cells were detached using trypsin-EDTA. Both 
populations of cells were washed, further resuspended in complete medium and mixed in 
1:1 ratio prior to seeding in 24-well plate. Fifteen hours post seeding cells were infected 
at a MOI of 0.5. At 24 hpi cells were washed with PBS, lysed with lysis buffer and 
supernatants were collected. Supernatant was mixed with luciferase assay substrate and 
the amount of relative fusion was obtained by measuring the relative level of 
luminescence (RLU) emitted measured using TD-20/20 luminometer (Turner Designs).  
Quantitative PCR 
Quantitative PCR (qPCR) was utilized to derive the total number of viral genomes within 
the lysate. Specifically, the primers and probe (6-carboxytetramethylrhodamine 
[TAMRA]) for the real-time PCR were designed to detect HSV-1 US6 (gD). Lysates 
were collected at 18 hpi, and 200 μl of each suspension was used for the extraction of 
viral DNA. Viral DNA was extracted using a DNeasy blood and tissue kit (Qiagen, Inc.) 
as per the manufacturer's instructions. Equal volumes of viral DNA were used for 
TaqMan PCR analysis. Purified HSV-1 bacterial artificial chromosome (YE102) DNA 
was used to generate the standard curve.  
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Confocal Microscopy 
Vero cell monolayers grown on eight-well glass Lab-Tek II chamber slide were infected 
with the indicated virus at an MOI of 10. Uninfected cells were used as negative controls. 
Cells were washed once with PBS and fixed with ice-cold 100% methanol for 10 minutes 
at 18 hpi. Monolayers were subsequently blocked for 1 h with 2% fetal calf serum in 
PBS. Further staining was done using mouse monoclonal anti-FLAG IgG1 (Sigma-
Aldrich, St. Louis, MO) for recognition of UL20p and TGOLN2 IgG2a (Abnova, 
Taiwan) for recognition of trans-Golgi network diluted 1:200 in PBS blocking buffer 
followed by Alexa Fluor 555-conjugated goat anti-mouse IgG1 and Alexa Fluor 488-
conjugated goat anti-mouse IgG2a secondary antibodies. Nucleus was stained using 4′, 6-
diamidino-2-phenylindole (DAPI). Specific immunofluorescence was examined using an 
Olympus FluoView confocal microscope. Image analysis and subcellular scatter plot 
graphs were generated and analyzed using the Olympus FluoView FV1000 confocal 
microscope software interface. Scatterplot graphs with colocalization of two fluorophores 
within the TGN were generated by specifically defining the regions of interest with a 
bounding box of equal area based on pixel enumeration for each captured image. To 
determine an approximate percentage of subcellular colocalization, pixel enumeration 
and intensity statistics within the Olympus software package were accumulated for each 
sample image. The percentage of upper right quadrant pixels from the total sample pixels 
was displayed. Finally images were compiled and rendered with Adobe Photoshop.  
Proximity Ligation Reaction (PLA) 
In situ PLA detection was carried out using the appropriate DUOLINK II In Situ kit 
components obtained from Sigma-Aldrich, St. Louis, MO. Vero cell monolayers grown 
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on eight-well glass Lab-Tek II chamber slide were infected with the indicated viruses at a 
MOI of 10. At 18 hpi cells were fixed using methanol for 10 minutes and blocked using 
DUOLINK blocking solution at 37°C in a wet chamber for 2 h. Primary antibodies used 
are anti-FLAG mouse (Sigma-Aldrich, St. Louis, MO) and anti-UL37 rabbit for the 
negative controls (mock infection and untagged wild type F strain) and for the wild type 
as well as the mutants. Whereas, primary antibodies used for positive control (gK-UL20p 
interaction) are anti-V5 mouse (Invitrogen Life Technologies) and anti-FLAG rabbit 
(Sigma-Aldrich, St. Louis, MO). Antibodies were diluted in blocking buffer and 
incubated in a wet chamber at 4°C overnight. The slides were washed two times with 1X 
TBS + 0.05% Tween 20 for 5 min each, then secondary antibodies (DUOLINK anti-
rabbit PLA-plus probe, DUOLINK anti-mouse PLA-minus probe) were added and 
incubated at 37°C for 1 h. Two washes with Duolink In situ wash buffer A for 5 min each 
were then followed by addition of the ligation mix and incubation in wet chamber at 
37°C for 30 min. After ligation slides were washed twice for 2 min using Duolink In situ 
wash buffer A before adding amplification reaction mix for 90 min at 37°C. Texas red–
labeled oligonucleotide detection probes (Olink Bioscience) were used. Subsequently, the 
slides were washed twice with Duolink In situ wash buffer B, and once with 0.1× 
Duolink In situ wash buffer B. Slides were mounted with Duolink In Situ Mounting 
Medium with DAPI and analyzed in a Olympus FluoView confocal microscope. 
Results 
Construction and Molecular Analysis of recombinant viruses 
 We have previously shown that deletion of the UL20p carboxyl terminal six-amino acids 
resulted in drastic inhibition of cytoplasmic virion envelopment and egress [17]. To 
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further investigate the potential role of phenylalanine residues within the carboxyl 
terminus of the UL20 protein, we constructed a cadre of mutant viruses for which one or 
more phenylalanine residues were replaced with alanine residues.  All mutant viruses 
were constructed using the markerless two-step Red recombination mutagenesis system 
implemented on the bacterial artificial chromosome (BAC) plasmid pYEbac102-VC1 
carrying the HSV-1(F) genome (see Materials and Methods). This virus expresses gK and 
UL20p tagged with V5 and 3xFLAG antigenic epitopes, respectively [30, 38].  The 
recombinant mutants included viruses having a deletion of the terminal phenylalanine 
residue (UL20∆Phe), deletion of six amino acids from the carboxyl terminus (UL20∆6), 
and replacement of one or two internal phenylalanine residues with alanines 
(UL20F222A, UL20F210A, and UL20F205-206A) (Fig. 3.1 and Table 3.1). The deletion 
mutants were made by the insertion of stop codon TAA in front of the last amino acid for 
UL20∆Phe and before the last 6 amino acids for UL20∆6. Similarly, for the amino acid 
replacement mutants, codons for phenylalanine (TTT or TTC) were replaced with the 
codon for alanine (GCA). Virus stocks were prepared after BAC transfection on FRT 
cells. Mutant viral genomes were characterized using PCR-assisted DNA sequencing, as 
well as whole genome sequencing approaches (see Materials and Methods section). 
Replication and Phenotypic characteristics of the mutant viruses 
The plaque morphologies of all mutant and wild-type viruses were examined on Vero 
cells (Fig. 3.2a) and FRT cells (Fig. 3.2b). As expected, the HSV-1(VC1) wild-type virus 
produced the largest virus plaques, while the UL20F205-206A, UL20∆6 produced 
smaller viral plaques when compared to the parental wild-type virus on Vero cells, while 
the recombinant viruses UL20∆Phe, UL20F222A produced syncytial plaques on Vero 
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cells (Fig. 2a).  All mutants produced wild-type-like plaques on FRT (Vero cells 
transformed to express the UL20 gene) cells (Fig. 2b). Western immunoblot analysis 
revealed that all viruses expressed similar levels of the UL20 protein (Fig. 3.3). To 
investigate the role of these mutations on the kinetics of viral replication, replication 
curves were produced for infections at both low (0.2) and high (2) MOI (Fig.3.4a, b).  At 
both high and low MOI, the UL20F205-206A mutant yielded the lowest end titer and 
UL20F210A mutant yielded the highest end titer when compared to wild-type virus. 
Importantly, the UL20F210A virus reproducibly produced approximately one log higher 
viral titers, when compared to the wild type virus at high MOI. At low MOI of 0.2, 
terminal viral titers of UL20∆6 and UL20F205-206A were 1 and 2 logs less, respectively 
in comparison to wild-type, while the UL20F210A mutant virus produced significantly 
higher viral titers than the wild-type virus. At MOI  2, the UL20F205-206A mutant virus 
titer was more than a log less than the wild-type virus.  
Quantification of cell-to-cell fusion. 
 Mutant viruses UL20∆Phe and UL20F222A produced syncytial plaques on Vero cells. 
The extent of virus-induced cell fusion was evaluated using a previously described 
luciferase assay [30] (see Materials and Methods). The gBΔ28syn mutant HSV-1 virus 
carrying a 28 amino acid deletion of the carboxyl terminus of gB causes extensive virus-
induced cell fusion [31] and was used as positive control. The relative levels of 
luminescence were measured for all samples at 24 hours hpi. Among mutant viruses, the  
UL20F222A produced the highest extent of fusion exhibiting RFU levels that were 
similar to those of the positive control gBΔ28syn virus (Fig. 3.5).  
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degrees of cytoplasmic defects in virion envelopment, as evidenced by the presence of 
numerous unenveloped or partially enveloped capsids in the cytoplasm of infected cells 
(Fig. 3.6). 
Characterization of the relative efficiency of cytoplasmic virion envelopment 
 A measure of the relative efficiency of infectious virion production is indicated in the 
ratio of total viral genomes produced in infected cells to the number of infectious virions 
determined by the standard plaque assay. In this regard, The UL20F205-206A mutation 
caused the most severe defect in the relative efficiency of infectious virion production 
followed by UL20∆6 mutant virus (Table3. 2). 
Intracellular localization of the UL20 mutant proteins and UL20 interactions with 
the UL37 protein 
 
 The intracellular location of wild-type and mutant UL20 proteins was investigated using 
confocal microscopy. All mutant viruses expressed UL20p that colocalized with the TGN 
marker TGOLN2. These visualization results were further supported by determination of 
the approximate percentage of subcellular co-localization using pixel enumeration and 
intensity statistics as detailed in Materials and Methods (Fig. 3.7). Recently, we showed 
that the UL37 protein physically interacted with the gK/UL20 protein complex to 
facilitate cytoplasmic virion envelopment. To investigate whether the engineered 
UL20mutations affected interactions between UL20p and UL37 proteins, we utilized the 
proximity ligation assay [39, 40] in conjunction with the anti-FLAG monoclonal antibody 
detecting the UL20-tagged protein and the anti-UL37 polyclonal antibody.  The known 
interactions between the UL20 protein and gK was also tested using the anti-FLAG 
(UL20) and anti-V5 (gK) antibodies, as a positive PLA control.  PLA produced vivid 
mutations affected interactions between UL20p and UL37 proteins, we utilized the 
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Table 3.2. Determination of viral genomes-to-PFU ratios. The total number of viral 
genomes infected Vero cells at 24 hpi were obtained by qPCR. The total number of 
intracellular infectious virions was obtained by plaque assay on FRT cells. Ratios 
reflecting relative efficiency of envelopment and infectious virion production were 
obtained by dividing the average of the number of viral genomes within infected cells by 
number of PFU. 
 
 
    
               Viruses 
 
Total HSV-1 genomes/PFU 
(in thousands) 
 
Wild- Type 
 
48 
UL20∆6 538 
UL20∆Phe 170 
UL20F222A 166 
UL20F210A 38 
UL20F205-206A 5648 
 
Discussion 
We have previously shown that the gK/UL20 protein complex serves crucial roles in 
cytoplasmic virion envelopment [9]. Our laboratory and others have shown that the UL37 
protein localizes to the TGN membranes and functions in cytoplasmic virion 
envelopment [41]. Recently, we showed that the UL37 protein interacts with the 
gK/UL20 protein complex and facilitates cytoplasmic virion envelopment and infectious 
virus production [27]. Herein, we show that phenylalanine residues located at the 
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carboxyl terminus of the UL20 protein are involved in the regulation of cytoplasmic 
virion envelopment and infectious virus production. 
We have previously reported the use of extensive alanine-scanning mutagenesis of the 
UL20 protein to delineate domains of the UL20 protein that function in cytoplasmic 
virion envelopment and virus-induced cell fusion [42]. Specifically, we showed that the 
amino terminus of the UL20 protein functioned in virus-induced cell fusion, while the 
carboxyl terminus was important for cytoplasmic virion envelopment [42]. Of specific 
interest to the current study was that deletion of the terminal six amino acids of the UL20 
protein drastically inhibited cytoplasmic virion envelopment, while it did not affect UL20 
protein interactions with gK and virus-induced cell fusion [42]. Based on our recent 
findings that the gK/UL20 protein complex interacts with the UL37 protein, we 
hypothesized that this interaction may occur between the carboxyl terminus of the UL20 
protein and the UL37 protein. These interactions may involve phenylalanine residues, 
which are known to facilitate protein-protein interactions through residue stacking and 
hydrophobic interactions.  Significantly, the UL20F210A mutation caused more than one 
log higher replication kinetics and final infectious virus production than wild-type virus 
on Vero cells at high MOI. Moreover, the ratio of total viral genomes to PFU was lower 
than that of the wild-type virus indicating that this mutation increases the efficiency of 
infectious virus production. The observed increase in the production of infectious virions 
reflects enhanced cytoplasmic virion envelopment, since it is unlikely that UL20 
mutations would affect other aspects of virion assembly such as capsid assembly in the 
nucleus. Moreover, the UL20F210A mutant virus produced higher infectious virus titers 
at high versus low MOI  in comparison to the parental wild-type virus suggesting that 
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enhancement in infectious virus production is dose-dependent on the expression of the 
UL20F210A protein.  
The UL20F210A “gain-of-function” mutation reveals that the phenylalanine (210) 
residue is involved in regulation of cytoplasmic virion envelopment and infectious virus 
production.  The purpose of this inhibitory mechanism is not immediately apparent. 
Infectious virus titers and particle to PFU ratios are affected by temperature with 
optimum virus titers and particle-to-PFU ratios produced at 34°C presumably because the 
entire process of virion assembly is more efficient at reduced assembly speed (Kousoulas, 
unpublished observations). Thus, it is possible that the process of cytoplasmic virion 
envelopment is down-regulated by UL20/gK to ensure efficient virion envelopment at 
37°C or higher. Alternatively, the replacement of the phenylalanine (210) may cause 
more efficient interaction of UL20p with other viral proteins or cellular proteins involved 
in cytoplasmic virion envelopment.  
The UL20F222A mutant virus caused extensive virus-induced cell fusion on Vero cells, 
which was completely inhibited on the UL20 complementing FRT cells. This result 
suggests that the phenylanine  residue at amino acid position 222 is involved in the 
regulation of membrane-fusion presumably because it alters the interactions of the 
gK/UL20 protein complex with the fusogenic glycoprotein gB.  All mutant viruses 
produced similar plaques with respect to size and fusogenic characteristics on FRT cells 
indicating that wild-type UL20p expression by FRT cells efficiently reverted all mutant 
phenotypes to that of the wild-type. Overall, these results suggest that the wild-type 
UL20p expressed by the FRT cells acts in a dominant manner to reverse the effect of 
these UL20 mutations presumably because it interacts more efficiently with gK, gB and 
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UL37.  Reversion of the phenotypic and growth properties of the UL20 mutant viruses 
indicates the absence of any other spurious mutations within the mutant viral genomes.  
This conclusion is further supported by PCR-assisted sequencing of targeted genomic 
areas and genomic sequencing of the wild-type and the UL20F201A genomes by next 
generation sequencing methodologies, which did not detect any spurious mutations. 
Phenylalanine replacement or deletion of carboxyl terminal regions of the UL20 protein 
that contained phenylalanine residues caused drastic defects in virion envelopment 
without affecting colocalization of the UL20 mutant proteins with the UL37 protein, as 
evidenced by similar PLA-produced fluorescent signals. Of particular interest is the 
mutagenesis of two membrane proximal phenylalanine residues to alanines.  This double 
amino acid replacement is predicted to cause retraction of the carboxyl terminus of the 
UL20 protein, so that it is no longer exposed to intracellular spaces (Fig. 3.9).  These 
results suggest that the carboxyl terminus of the UL20 protein is not a major contributor 
to overall interactions with the UL37 protein. Alternatively, mutagenesis of the carboxyl 
terminus of the UL20 protein may negatively affect other functional aspects of the overall 
interactions of the gK/UL20 complex, as well as its potential domain- specific affinity to 
UL37 or other tegument proteins causing inhibition or enhancement of cytoplasmic 
virion envelopment and infectious virus production.  
Cytoplasmic virion envelopment has been thought to involve a series of complex 
interactions between viral glycoproteins embedded in the TGN membranes and 
teguments proteins found on cytoplasmic capsids, or bound to TGN membranes. Results, 
herein, show that cytoplasmic virion envelopment is a dynamic process where 
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certain cells, where the virus may need to control the rate of infectious virus production. 
The UL20F210A gain of function mutation can be incorporated into other mutant herpes 
viruses engineered for anticancer or gene therapy purpose to enhance their beneficial 
functions or to alleviate their defects in replication efficiencies and produce higher titers 
of virus.  Further studies are required to explore this gain of function behavior of the 
mutant virus and to investigate whether the mutation has any effect on the pathogenesis 
of the virus in experimental animal infections.  
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CHAPTER IV 
ENTRY CHARACTERISTICS OF HSV-1 gK 31-68 MUTANT IN VERO CELLS 
AND NEURONS STUDIED USING UL37 PROTEIN/DYNEIN PLA ASSAY 
 
Significance 
Cytoplasmic dyneins are known to transport cargoes in a retrograde manner, which is 
towards the center of the cell. We show here for the first time utilizing PLA, that in both 
epithelial cells and neuronal ganglia, the motor protein dynein potentially interacts with 
the HSV-1 inner tegument protein UL37 upon release of the cytosolic capsids in to the 
cytosol of the host cell. PLA, is a valuable tool to detect protein-protein interaction that 
overcomes the non-specificity of antibody approach or the difficulties associated with co-
immunoprecipitation assay when relatively large hydrophobic membrane proteins are 
involved. The interaction between UL37 and dynein was seen as early as 30 minutes after 
entry and continued till 14 hrs. However, it was considerably reduced and almost 
completely absent at 16 hours post entry. This interaction was much pronounced in the 
wild type virus after one hour post infection, when compared to the gK 31-68 mutant 
virus which has been shown to enter relatively slowly in Vero cells. This clearly implies 
that upon losing the envelope on the cell surface, the viral capsids with the tegument 
proteins interact with dynein and utilize the microtubular network to be transported to the 
nucleus. 
Introduction 
 Herpes Simplex Virus-1 (HSV-1) predominantly enters Vero cells by the fusion 
mechanism, where the viral envelope fuses with the cellular plasma membranes in a pH-
independent manner. While fusion remains the only mode of entry of HSV-1 in neuronal 
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cells[1], entry of the virus in non-neuronal cells can also occur by receptor-mediated 
endocytosis where the low pH milieu of the endosomes causes the fusion to takes place 
between the viral envelope and the endocytic membranes [2]. Virus-induced cell fusion 
mediated by viral glycoproteins helps the virus to spread from infected cells to uninfected 
cells without being exposed to extracellular spaces [3]. 
HSV-1 encodes at least 26 tegument proteins and 11 virally encoded glycoproteins, as 
well as several non-glycosylated membrane associated proteins. The viral glycoproteins 
gD, gB, gH, and gL have been known to be involved in virion entry, while gC has been 
known to enhance initial binding of the virus to host cell membranes [4-8]. The virion 
entry is thought to be initiated by the binding of glycoproteins gB and gC to 
glycosaminoglycan (GAG) moieties of cell surface proteoglycans [9]. This initial 
attachment causes  the interaction of gD with one or more of its specific receptors, 
including the herpesvirus entry mediator (HVEM,or HveA), nectin-1 (HVeC), 3-o-
heparan sulfate and additionally PILR-α, NMHC-IIA, and myelin associated 
glycoprotein(MAG), that facilitates virion attachment and virus entry[10]. 
 After fusion of the viral glycoproteins with the host plasma membrane, the tegument 
proteins and the capsid containing the DNA are released in to the cytosol. For efficient 
replication of the viral DNA in the nucleus of the infected cell, the capsid has to be 
transported from the plasma membrane across the cytosol to the nuclear membrane. 
Diffusion cannot be utilized by the HSV-1 capsid across the cytoplasm as it has been 
calculated that a HSV capsid would take over 200 years to travel just 1cm if diffusion 
was the only mode of transport[11].  In case of neurons that have the cell body, dendrites 
and an axon, where the dendrites are highly branched and elongated and an axon which 
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can be as long as one meter, diffusion cannot be utilized as the optimal means of 
transport .These cytosolic capsids are ably transported to the nucleus along the 
microtubules [12]. HSV-1 an alphaherpesvirus undergoes replication in the epithelial 
cells of the host at the site of infection before entering the nervous system. The viral 
particles enter the peripheral nervous system where they are transported towards the cell 
body in a retrograde manner to initiate latent infection in the sensory neurons of the 
dorsal root and trigeminal ganglia. However, reactivation of the virus from latency causes 
the viral particles to be transported to the periphery in an anterograde manner.  In case of 
neuronal cells as well, the capsids are transported along the axons to the neuronal cell 
body, which utilizes the microtubule network. The capsids have been shown to move in 
minus end direction towards the microtubular organizing centers (MTOC)[13]. 
Cytoplasmic dyneins are known to transport payloads towards the minus end of 
microtubules (retrograde transport), which is usually the center of the cell, while kinesin 
motors usually transport payloads towards the plus end of microtubules (anterograde 
transport) which is the cell periphery [14-16]. The retrograde transport of the capsids has 
been shown to be disrupted when the cells are pretreated with microtubule 
depolymerizing agents such as nocodazole or colchicine suggesting that the microtubule 
network is required for entry into the nucleus[13, 17]. 
These cargo transporters, are usually made up of multiple subunits with their molecular 
weights ranging from 1.5 MD for dynein, 1.2 MD for dynactin, 340-380 kDa for kinesin-
1 and 260-280 kDa for kinesin-2 (Plus and minus end paper).  Dynein belongs to the 
AAA+ superfamily (ATPase associated with various cellular activities),  and cytoplasmic 
dynein is a large complex made of two heavy chains (DHCs), two intermediate chains 
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(ICs), two light intermediate chains (LICs) and several light chains (LCs) [14, 18]. The 
heavy chain consists of the cargo binding domain (N-terminus) and the motor domain (C-
terminus) made up of six AAA ATPase domains in the form of a hexameric ring that 
causes the movement by utilizing the energy released during ATP hydrolysis [19] and has 
a stalk that binds to microtubule [20]. Alpha herpes viruses such as HSV-1,  pseudorabies 
virus (PrV) and the retrovirus human immunodeficiency virus type 1 (HIV-1) and 
adenovirus, exploit cytoplasmic dynein of the host cell which along with its co-factor 
dynactin, causes their directional movement towards the MTOC during their initial stages 
of infection [21, 22]. Majority of the outer tegument proteins remain at the plasma 
membrane along with the glycoproteins upon fusion of the virus at the cell membrane 
causing the inner tegument proteins attached to the viral capsids to be exposed in the 
cytoplasm [23, 24]. Experiments have shown that purified dynein motor can bind to 
tegumented capsids and do not depend on the presence of any host proteins for this 
binding. Lack of capsid proteins such as VP26, pUS11or VP11/12 did not seem to affect 
the transport of these capsids to the nucleus and thus may less likely have the binding 
sites for the dynein motors. These interactions are further supported by in vitro 
experiments in which capsids complexed with inner tegument proteins were able to 
associate with the microtubule motors, while the capsids lacking the tegument proteins 
did not [25].Also, the failure of nuclear capsids to bind to the MAPs (microtubule 
associated proteins) would suggest that the tegument proteins are more likely the 
candidates for binding the motor proteins. Studies using recombinant viruses having 
different tagged viral proteins for tracking showed that the major tegument proteins UL36 
and UL37 can be detected in capsids undergoing retrograde transport  in neuronal cells 
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and this protein complex along with the capsid persisted together even after reaching the 
nuclear membrane, while majority of the other tegument proteins are lost from the 
capsids during this transport, similar to the findings in epithelial cells [21, 26, 27]. Thus 
these inner tegument proteins UL36 and UL37 may be a few of other proteins that serve 
as strong candidates that potentially recruit dynein motor [28, 29].  The HSV-1 UL37 is a 
120kDa phosphorylated tegument protein expressed in both mature virions and light 
particles [30]. UL37 protein is known to interact with proteins pUL46,  pUL35 [31, 32] 
and pUL36 and this interaction of pUL37 with pUL36 is known to be critical for 
transport to the TGN [33, 34]. The pUL36 interacts with the outer tegument protein 
pUL48 [32] and the minor capsid protein pUL25 [35, 36]  In addition to envelopment, 
which is associated with egress, pUL36 and pUL37 have also been implicated in 
intracellular transport, as it has been shown in both HSV1 and PrV that lack of either one 
of these proteins impairs the intracellular trafficking of viral capsids to the nucleus [37]. 
Here we show by proximity ligation assay (PLA), a sensitive method to detect protein-
protein interaction, that pUL37 potentially interacts with dynein motor protein during 
entry. This interaction is visualized as bright red spots of fluorescence and the interaction 
seems to be occur starting as early as 30 minutes post infection and seem to persist 2 hrs 
post entry, while very minimal to no signal is detected after 16 hrs, indicating that may be 
at 16 hpi the dynein motors may not be engaged with the viral capsids and the nuclear 
capsids might be associated with kinesin motors which aid in the transport of the capsids 
towards the plasma membrane of the cell.   
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Materials and Methods 
Cell Lines 
African green monkey kidney (Vero) cells were obtained from the American Type 
Culture Collection (Rockville, MD) and was maintained in Dulbecco’s modified Eagle’s 
medium (Gibco-BRL; Grand Island, N.Y.), supplemented with 10% fetal calf serum and 
antibiotics. CHO-nectin-1(human) cells were a gift from Richard Longnecker 
(Northwestern University, Chicago, IL) and CHO-neo cells were a gift from Yasushi 
Kawaguchi (The University of Tokyo, Japan).  Both these cell lines were propagated in 
Ham's F12 growth medium supplemented with 10% FBS and 200 μg/ml G418 and 250 
μg/ml G418 respectively. 
In situ proximity ligation assay analysis of protein interactions in virus infected 
cells. 
Vero cells were grown on 8 well chamber slides (Nunc Lab-Tek II chamber slide system) 
and infected with F strain virus at an MOI of 10. At 18 hours post infection, the cells 
were fixed with ice cold methanol for 10 minutes at -20°C. After three washes with PBS, 
the samples were blocked for 2 hrs at 37°C with the Duolink blocking buffer in a 
humidity chamber. Primary antibodies that were raised in two different species were 
diluted in antibody diluting buffer and added to the samples and were incubated 
overnight at 4°C. Mouse anti-dynein antibody against intermediate chain I (Abcam) and 
rabbit anti-UL37 antibody (a gift from Dr. Frank J. Jenkins, University of Pittsburgh 
Cancer Institute) were used for dynein/UL37 detection, respectively in Vero, CHO-neo 
and CHO-nectin cells. Mouse anti-gD antibody and rabbit anti-nectin-1 antibody (Santa 
Cruz) was used for positive control for gD/nectin-1 interaction in Vero cells. Mouse anti-
dynein antibody and rabbit anti-gM antibody was used as negative control for dynein/gM 
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interaction on Vero, CHO-neo and CHO-nectin-1 cells. Anti-microtubule antibody 
(Abcam) was used for microtubule detection. Unbound primary antibodies were removed 
by washing with 1X TBS-Tween20 (0.05%) three times, five minutes each. The Duolink 
insitu PLA probes, Anti-Rabbit Plus and Anti-Mouse Minus, were added to the samples 
(1:5 dilution) and incubated at 37°C for 1hr. After the incubation step, washes were done 
with Duolink wash buffer A, twice for five minutes each. The ligation stock was diluted 
1:5 in high purity water and added to the wells (40 to 80ul) and the slides were incubated 
at 37°C for 30 minutes. The slides were washed with buffer A three times, five minutes 
each and amplification solution (40 to 50ul) was added and were incubated for 1.5 hrs at 
37°C. The slides were then washed with wash buffer B twice for 10 minutes each and 
washed once with 0.01% of buffer B. The slides were then mounted with mounting media 
(Duolink II) and the slides were stored at -20°C and protected from light until confocal 
images were taken. The confocal images were taken using a 60X objective on an 
Olympus FluoView FV10i confocal laser scanning microscope. 
The virus was allowed to attach to confluent monolayer of vero cells at 4°C for 1hour and 
shifted to 37°C to allow virus entry and the chamber slides were removed  at various time 
points 0, 30, 2 hrs, 3 hrs, 6 hrs, 9 hrs, and 12 hrs and fixed with ice-cold methanol and 
proceeded with proximity ligation assay. 
In situ proximity ligation assay analysis of protein interactions in virus infected 
dorsal root ganglia 
 Dorsal Root Ganglia were dissected from fetal Sprague-Dawley rats at embryonic days 8 
to 10 and seeded on Poly-D-Lysine 8-well Culture Slides (Catalog number: 354632 BD). 
Similarly aged Rat DRG was also obtained commercially (Catalog number: DRG – 
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BrainBits). Maintenance tissue culture medium consisted of neural basal medium with B-
27 supplement, at the manufacturer’s recommended concentration (Invitrogen, Grand 
Island, NY). Medium was supplemented with 50 ng/ml neural growth factor 2.5s 
(Invitrogen), 2%normal rat serum (Invitrogen), 1_GlutaMAX (Invitrogen), and 0.2% 
Primocin (InvivoGen, San Diego, CA). The ganglia were monitored regularly for axonal 
growth and supplemented with neuro-basal media supplemented with neuronal growth 
factors. A healthy extension of axons was observed 7 days post seeding and the ganglia 
were ready to be infected.  The media was then removed and 200,000 PFU of either wild-
type McKrae or mutant gKΔ31-68 virus was added to the ganglia. The virus was 
removed after 1 hour incubation time at 37C and the slides were fixed with ice cold 
methanol for 10 minutes at -200C. PLA assay was performed on these slides as described 
earlier. 
Results 
The inner tegument protein UL37 interacts with the motor protein dynein during 
transport of the viral capsids to the nucleus 
Proximity ligation assay shows the interaction of the tegument protein UL37 with the 
motor protein dynein. This interaction is visualized as bright red spots of fluorescence 
which can be seen starting from 30 minutes post entry. After the initial attachment of the 
virus to the cell, glycoprotein D is known to interact with one or more of its specific 
receptors causing virion attachment and entry. We utilized nectin-1 which is one of its 
specific receptors for our positive control. Bright red fluorescent signals were visualized 
which shows the interaction of gD with nectin-1 at zero time point. The gM /dynein 
combination was used as negative control for both zero and 16 hrs time points, because 
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after the fusion of viral glycoproteins with the host cell membrane only the tegument 
proteins and the capsid containing DNA are released in to the cytosol of the host cell. 
Consequently, gM dynein interaction is physically improbable. As expected, no red 
fluorescence signals were seen indicating the absence of gM-dynein interaction.  
For the pUL37-dynein interaction, the virus was allowed to attach to the cells for 1 hr at 
4°C followed by incubation times  0 min, 30 min, 2 hrs, 6 hrs, 9 hrs, 12 hrs, 14 hrs and 16 
hrs at 37°C  to allow virus entry. The signals were seen at all-time points except for 0 
minutes. Visually, the signals seemed to be a maximum at 30 minutes with some seen at 
2 and 6 hrs. At 9 hrs post entry, the signals seemed to have a pattern where they 
accumulated around the nucleus. Although, at 12, 14 and 16 hrs post entry the signals 
seemed to dissipate and were minimal (Fig 2 A & B).  
We have shown previously that the gK 31-68 virus (the first 68 aa deleted which includes 
the first 30aa signal sequence) enters very slowly in the Vero cells when compared to the 
wild type virus. Here we saw only a few signals for the pUL37-Dynein interaction for the 
gK 31-68 virus showing the slow entry of the virus into the cells compared to the wild 
type, however the signals for gD-nectin-1 interaction in both the viruses appeared to be 
similar.  
Dorsal root ganglia resected from 8-10 day old Sprague-Dawley rat embryos were seeded 
on PLL coated 8 well chambered slides and cultured in neuro basal medium 
supplemented with neuronal growth factors. The Ganglia exhibited robust growth of 
axons 7 days post seeding and were used for infection studies. As with Vero cells gM-
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Dynein interaction was used negative control. Red fluorescent signals representing gD-
Nectin interaction were observed on the axonal surface in the case of both wild type 
 
Figure 4.2. Proximity ligation assay of UL37- dynein interaction on Vero cells. Confluent 
Vero cells were grown on 8 well chamber slides. HSV-1 F strain virus at an MOI of 10 
was used to infect the Vero cells and the slides were rocked at 4°C for one hour for the 
binding of virus to the cells and shifted to 37°C to aloe entry. The cells were fixed with 
ice-cold methanol for 10 minutes at -20°C followed by proximity ligation reaction as 
described in the materials and methods. gM/dynein antibody pair was used as a negative 
control and it was used for 30 min and 16 hrs time point while gD/nectin-1 antibody pair 
was used as positive control at zero time point (A), The remaining time points utilized 
pUL37/dynein antibody pair to determine the interaction of these two proteins at different 
time points post entry. The virus was allowed to enter at varying time points, 0, 30 min, 2 
hrs, 6 hrs, 9 hrs, 12 hrs, 14 hrs and 16 hrs (B) 
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Figure 4.3. Comparison of UL37/dynein interaction in WT and gK 31-68 viruses. 
Confluent Vero cells grown on 8 well chamber slides were infected with HSV-1 F strain 
virus at an MOI of 10. The slides were rocked at 4C for binding of virus to the cells for 
one hour and shifted to 34C to allow entry. At one hour post infection, the virus was 
removed and cells were fixed and PLA assay was performed as described in materials 
and methods. Interaction between gD and nectin-1 was studied in both these viruses as 
control (A). UL37/dynein antibody pair was used to study the interaction between these 
proteins in the cells (B).  
 
Dorsal root ganglia resected from 8-10 day old Sprague-Dawley rat embryos were seeded 
on PLL coated 8 well chambered slides and cultured in neuro basal medium 
supplemented with neuronal growth factors. The Ganglia exhibited robust growth of 
axons 7 days post seeding and were used for infection studies. As with Vero cells gM-
Dynein interaction was used negative control. Red fluorescent signals representing gD-
Nectin interaction were observed on the axonal surface in the case of both wild type 
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McKrae as well as gK31-68 infections. In DRG axons infected with wild type virus the 
pUL37-Dynein probe combination yielded Red signals indicating the entry of the virus 
and interaction of UL37 with dynein. However no such signal was observed in DRG 
axons infected with gKΔ31-68 which suggest that the virus was stuck on the surface. As 
with Veros the gM-Dynein combination did not yield any signals (Fig 4 A, B, C, & D). 
Discussion 
Many new techniques and methods come in to existence in the field of proteomics that 
help us to understand and acquire insights in protein structure, functions, modifications 
and interactions and so on. 
PLA is a relatively simple tool to detect protein-protein interactions. This technique has 
also been utilized for detecting infectious agents and proteins with a sensitivity rated 
higher than much established technique like PCR [38]. Here we have used the technique 
to understand the entry and transport of HSV-1 towards nucleus. This technique can be 
utilized to detect the entry of virus to the cytosol of infected cells even if the virus fails to 
enter nucleus and start protein synthesis Thus is helpful in differentiating between virus 
stuck at the cell plasma membrane or inside the cell giving more insight into which steps 
of viral life-cycle are affected.  The HSV-1 proteins shown to be interacting with dynein 
are nuclear protein UL34 through GST pulldown experiment and capsid protein VP5 and 
helicase UL9 using Pepscan [39]. Through biochemical analysis and live imaging suggest 
VP1/2 (UL36) and UL37 are the two most suspected candidates for interacting with 
dynein [37]. We are able to report the proximity between cellular motor protein dynein 
and the herpes viral tegument protein UL37. Our data suggested close physical 
interaction between dynein and UL37 throughout replication cycle. Studies showing 
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interactions between viral proteins and cellular motors are very limited and part of the 
reason may be because dyneins are tremendously large multimeric proteins with 
molecular mass ranging from 1,000K-2,000K [40]. In this scenario, PLA can be used to 
unfold the mysteries of protein-protein interactions rather than opting for the difficult 
techniques of immunoprecipitation and western blots. It is shown that at zero min there is 
no interaction between the two proteins as the virus has not even entered the cells and the 
interaction shows up at later time points. Negative control experiments using membrane 
protein gM and dynein did not show any interaction at both early and late time points. 
This clearly supports the belief that it is not the membrane proteins, but the outer capsid 
or inner tegument proteins are involved in cellular transport of virus.  The interaction 
between pUL37 and dynein starts from the time of viral entry to cells, then intensifies and 
cluster around nine hours and finally disseminate and vanishes towards later time point. 
Clustering of interaction during egress suggest that dynein may have a passive role 
during exit by being part of the motor system and also more pUL37 is present as new 
viruses are being made Further works need to be done to dissect where the interactions 
between dynein and UL37 is happening.  
Our lab has shown that the gK mutant virus, gKΔ31-68 lacking 68 aa from its amino 
terminus (including the 30-aa signal sequence) entered vero cells less efficiently 
compared to wild-type virus [3]. Through PLA we have supported the observation by 
showing fewer signals for pUL37-Dynein interaction for gKΔ31-68 when compared to 
wild-type virus though the interaction between gD-nectin remained similar for both the 
viruses showing that the attachment between virus and cell was not affected by the 
mutation on gK . A critical aspect of the life cycle of HSV-1 is the entry into axons and 
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establishment of latency in the ganglia. With the development of HSV-1 as a highly 
potent oncolytic vector/vaccine, it is of critical importance to develop recombinant HSV-
1 strains capable of delivering oncolytic payloads, without infecting axons and 
establishing latency in the ganglia. We believe that 31-68 aa region of the amino- 
terminal region of HSV-1 glycoprotein K plays a critical role in modulating gB mediated 
entry into axons. In order to prove this hypothesis we have seeded dorsal root ganglia 
resected from 8-10 Sprague-Dawley rat embryos to seed them on poly-L Lysine coated * 
well chambered slides. In presence of Neuronal growth factors, a robust growth of axonal 
fibers extending away from the neuronal bodies within the ganglionic cluster was 
observed. Infection of these axonal regions with both wild type McKrae and gKΔ31-68 
virus followed by the proximity ligation assay similar to the vero studies described earlier 
reinforced our hypothesis. In the case of the wild type infections, red fluorescent signals 
were observed for both gD/Nectin as well pUL37-Dynein combination. However in the 
case of gKΔ31-68 red fluorescent signals were observed only for the gD/Nectin 
interaction. The absence of pUL37-Dynein interaction in gKΔ31-68 infections suggest 
that i) either the virus is unable to enter the axons and is stuck on the surface or ii) 
gKΔ31-68 is altering the configuration of UL37 rendering it incapable of interacting with 
Dynein axons. The latter is a highly unlikely scenario with no empirical evidence to 
support it and  also as virus loses its membrane proteins and many tegument proteins 
subsequent to the entry into cell after fusion This interaction study demonstrates one of 
the practical applications of PLA. Thus PLA can be used as a very convenient and useful 
tool in exploring the life-cycle events of the virus. 
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CHAPTER V 
CONCLUDING REMARKS 
 
 
Summary 
 
   The Herpes Simplex virus has a very complex life cycle and in which envelopment and 
egress are important events. Viral membrane proteins and tegument proteins functions 
together in order to get the virus successfully envelop and egress out of the cell. The 
important membrane proteins required for the step are glycoproteins gM, gK, gE and 
non-glycosylated membrane proteins UL20 and UL11. Among all the most important is 
the UL20/gK complex [1]. UL20p is a structural protein made of 222 amino-acids which 
is non-glycosylated and has transmembrane domains. It is highly conserved among 
alphaherpesviruses like varicella-zoster [2], pseudorabies virus (PRV) [3] and the 
gammaherpesvirus Marek’s disease virus type 2 [4]. Works done in my laboratories have 
show that UL20p deletion resulted in accumulation of unenveloped capsids in the 
cytoplasm of infected cells [5] . Mutant viruses were made with mutations in the carboxyl 
termini of UL20p especially targeting Phenylalanine residues which may be an important 
target for protein-protein interactions through stacking of the aromatic structure. The 
mutation of approximately middle phenylalanine to alanines has an advantageous effect 
on the virus as evidence by an increased titer at end the replication study and also a lower 
particle to PFU ratio reflecting the higher efficiency of viral envelopment.  Another 
important observation of the study was the importance of the double phenylalanine 
residue proximal to the membrane. Replacement of those phenylalanines to alanines 
affected the replication capabilities of the virus and also the envelopment efficiencies. 
The protein structure predicted by SOSUI programme showed that the carboxyl terminal 
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is retracted from the intracellular space and this might have affected the ability of the 
protein to interact with tegument proteins during envelopment.  
In the second study, we have showed that the deletion of amino terminus of viral envelop 
protein gK has affected the entry of HSV-1 into Vero cells and neurons through PLA 
technique. gK like UL20p has multiple transmembrane regions and is made of 338 amino 
acids encoded by the UL53 open reading frame . PLA is a sensitive method to detect 
protein-protein interaction [6]. After entry to cell, virus recruits cellular motor proteins 
for their transport to the nucleus and for the retrograde transport dynein is the motor 
protein of interest. The most suspected tegument protein interacting with dynein is the 
inner tegument protein of virus UL37. PLA technique has been standardized to show the 
interaction between UL37 protein and dynein. Here the technique has been successfully 
shown the entry and transport of HSV-1 towards the nucleus and can be used as a method 
to evaluate viral entry to the cytoplasm of infected cell. Using the technique it has been 
shown that the gKΔ31-68 lacking 68 aa from its amino terminus entered slowly into vero 
cells and in case of neurons there is complete absence of signals indicating the inability 
of the virus to enter neurons. It is interesting to note that the viral attachment to cell 
surface is not affected in either case suggesting the later step after entry is affected and 
deletion of amino terminus of gK is not hindering the attachment step. 
Future Studies 
In chapter II, phenylalanine residues at the carboxyl terminus of UL20p has been shown 
have regulator effect on infectious virus production and envelopment. Additional work 
need to be done to further understand the how the deletion or replacement is affecting 
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envelopment and egress of the mutant viruses. Peptides of UL20 carboxyl terminus can 
be used to study whether they are able to complement the behavior of mutant viruses. 
Plans are there to use the viruses in an invitro neuronal system to study the anterograde 
and retrograde transport and to have a better understanding about the behavior of virus in 
neurons. Furthermore, mice can be infected with the viruses to study pathogenesis of 
infection. 
In chapter III, PLA was used to support and explore the role of amino terminus of gK in 
entry to Vero cells and neurons respectively. This technique is a valuable tool to detect 
the entry of virus to cells. It can be used to study similar entry defects in different 
membrane proteins mutant viruses and used to explore which all domains are critical for 
entry. Apart from entry, egress can also be studied by using the different motor protein 
kinesins, which  are important for anterograde transport. Thus PLA can be used as a very 
convenient and useful tool in exploring the life-cycle events of the virus.  
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